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Toll-like receptors (TLRs), named after toll proteins identified in Drosophila 
melanogaster, are the pattern recognition receptors in the innate immune system that 
detect microbes. TLRs are mono, membrane-spanning, as well as non-catalytic receptors, 
which are mainly expressed in sentinel cells, such as the dendritic cells, neutrophils and 
macrophages. While humans have ten TLRs (TLR 1 to 10), the mouse has another three 
(TLRs 11, 12, 13). TLRs are made up of glycoproteins, which have luminal ligand-
binding sites consisting of leucine-rich repeat (LRR) for detection of pathogens leading to 
activation of immune cells. TLR1, 2, 4, and 6 are responsible for recognition of lipids 
(such as triacetylated lipopeptide), peptidoglycan, and lipopolysaccharide (LPS). 
However, the TLR3, 7, 8, and 9 mainly recognize nucleic acids, such as double-stranded 
RNA (dsRNA) and CpG DNA, while the TLR13 detects ribosomal RNA sequences. So 
far, there are no data on the localization and immunological functions of TLR10.  
I studied the expression, localization and role of TLR10 in S. pneumoniae 
infection. First, I examined the expression of TLR10 in lungs of pig, cattle, dog, rat, and 
chickens. The light and electron microscopic data show TLR10 expression in vascular 
endothelium and smooth muscles in lungs of control and inflamed animals. Further, we 
found altered basal level of expression and localization of TLR10 in bovine neutrophils 
treated with E. coli lipopolysaccharide. These data show the expression of TLR10 in the 
lungs of tested animal species, and its alteration by LPS in bovine neutrophils.  
The next study was designed to investigate the regulation of TLR10 expression 
and to address its role in neutrophil chemotaxis. E. coli LPS activated human neutrophils 
showed temporal and spatial change in TLR10 expression. Confocal microscopy showed 
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cytosolic and nuclear distribution of TLR10 in normal and activated neutrophils. TLR10 
in E. coli LPS-activated neutrophils colocalized with flotallin-1, a lipid raft marker, and 
EEA-1, an early endosomal marker, suggested its endocytosis. Live cell imaging of LPS 
activated neutrophils showed TLR10 translocation to the leading edge. Neutrophils upon 
TLR10 knockdown were unable for fMLP-induced migration. TLR10 knockdown 
reduced the number of membrane pseudopods in activated neutrophils without altering 
the expression of key proteins of actin nucleation process, ARP-3 and Diap1. These data 
show TLR4-mediated pathway for regulation of TLR10 expression, and that TLR10 may 
have a role in neutrophil chemotaxis. 
Next, I examined the role of TLR10 in innate immune response to S. pneumoniae 
infection in U937 human macrophage cell line. S. pneumoniae are major causative agents 
of pneumonia, meningitis and bacteremia. A significant increase in TLR10 mRNA 
expression was found in S. pneumoniae (107 cfu for 6hr) challenged macrophages. 
TLR10 knockdown significantly reduced production of IL-1β, IL-8, IL-17 and TNF-α 
and no significant change in IL-10 expression, and also significantly diminished nuclear 
translocation of NF-κB but without affecting the phagocytosis of S. pneumoniae.  
Altogether, I report the that TLR10 is expressed in the normal and inflamed lungs 
in cattle, pigs, dogs, rats, chickens and humans. The expression of TLR10 is altered in 
activated neutrophils, and it plays a role in neutrophils chemotaxis and production of pro-
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CHAPTER. 1 REVIEW OF LITERATURE 
1.1 Introduction 
The respiratory tract continuously samples the outer environment and is a primary 
site for the pathogen entry into the body.  It has a surface area of approximately 75m2 in 
humans and failure to clear pathogens from this area will lead to airway inflammation or 
respiratory tract infection (Smith, 1994). Before the discovery of DNA sequencing and 
ribotying, the trachea and pharyngeal area were thought to be a sterile environment in a 
normal organism because of ineffective methods to culture and isolate microorganisms 
from these sites. Lung inflammation caused by lung microbiota disproportion or invading 
pathogens results in significant morbidity and mortality in human and animal health care 
(Lambrecht and Hammad, 2015). According to the annual reports of the Asthma Society 
of Canada, the economic burden of respiratory illnesses is $5.9 billion annually 
(Asthma.ca, 2011).  
In humans, respiratory diseases and lung inflammation lead to clinical conditions 
such as acute lung injury (ALI), acute respiratory distress syndrome (ARDS), and chronic 
lung injury (CLI) causing significant morbidity and mortality. ALI is characterized by 
disruption of endothelial and epithelial barriers, infiltration of immune cells, such as 
neutrophils, to the site of injury, and a life-threatening escalation of lung inflammation 
(Donahoe, 2011). Chronic inflammatory lung diseases such as asthma are characterized 
by airway hyper-responsiveness leading to airway tissue remodeling and reduced lung 
function (Johnson and Matthay, 2010). 
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The first line of defense against the microbial invasion of the respiratory system is 
composed of mechanical barriers such as the mucociliary layer composed of ciliated 
cells, and secretions of goblet cells and sub-epithelial glands (Nicod, 2005).  The innate 
immune system has a variety of cells expressing pathogen recognition receptors (PRRs) 
to recognize the pathogen associated molecular patterns (PAMPs) of pathogens that 
escape mechanical barriers (Iwasaki and Medzhitov, 2015). PRRs, such as toll-like 
receptors (TLRs), NOD-like receptors (NLRs), RIG-1- like receptors (RLRs) are 
designed to recognize pathogens and trigger the host immune response (Iwasaki and 
Medzhitov, 2015).  
Toll receptors were first identified in Drosophila as a receptor associated with 
embryonic pattern development (Anderson et al., 1985; Hashimoto et al., 1988). A 
decade later these receptors were reported to have immune reactivity against fungal 
infection (Medzhitov et al., 1997). Mammalian homologue of Toll proteins, defined as 
Toll-like receptors, were identified and reported to play a role in bacterial LPS-mediated 
inflammation (Takeuchi and Akira, 2002). Currently, 13 TLRs have been identified with 
each TLR executing innate immune responses. TLRs also recognize intracellular ligands 
including proteins and peptides, polysaccharides, peptidoglycans, nucleic acids, and 
phospholipids, which are critical structural building blocks of cells and their extracellular 
matrix (Beutler, 2009). 
The important role of TLRs in the detection of pathogens and progression of 
inflammation makes them ideal drug target candidates. This body of work is the result of 
investigating TLR10, a recent addition of TLR family of proteins, whose ligand is still 
unknown.  Specifically, I examined the expression of TLR10 in multiple species, 
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regulation of its expression and function in neutrophils, and the role of TLR10 in 
Streptococcus pneumoniae infection.  
 
1.2 Respiratory diseases in humans 
New or established human respiratory diseases cause significant mortality and 
morbidity due to drug resistant pathogens and lack of complete understanding of disease 
pathogenesis.  The two clinical conditions affecting the lung that were relevant to this 
thesis are described below.  
 
1.2.1 Acute lung injury 
ALI is a complex respiratory disorder characterized by non-hydrostatic 
pulmonary edema and acute capillary injury. ALI patients manifest rapid breathing 
(tachypnea), hypoxemia, loss of lung compliance and pulmonary infiltration of immune 
cells (Meng et al., 2010). ALI can be caused by an infectious agent, such as bacterial or 
viral infections, or occur as a sequel to non-pulmonary disease processes, such as acute 
pancreatitis or sepsis.   Since ALI has an acute-onset of noncardiogenic or nonhydrostatic 
pulmonary edema, defined by a PaO2/FIO2 ratio lower than 300 and acute-onset 
neutrophil-dominant inflammatory lung disease, the neutrophil-epithelial interactions are 
important in maintaining the barrier function (Fujishima, 2011). During endotoxin-
induced ALI, neutrophils are recruited from the circulation and bone marrow to the lung 
through the functions of many proteins such as Stromal Derived Factor 1 (SDF1), a 
chemokine produced by injured epithelium. Specific cytokines (e.g. TNF-α, IFN-γ and 
IL-8) produced in response to pathogenic invasion regulate the barrier properties of lung 
microvasculature (Sedwick, 2012; Mouratis et al., 2015). Alveolar epithelial injury 
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causes reduced surfactant production, which further reduces fluid transport and increases 
the accumulation of alveolar edema (Matthay and Kronish, 1990). During ALI, the 
endothelial integrity is damaged and endothelium-dependent relaxation of selectively 
injured endothelium results in pulmonary vessels contraction and relaxation, which 
eventually leads to pulmonary hypertension (Imai et al., 2005; Price et al., 2012).  
Neutrophil migration is common in barrier dysfunction and they move along the 
endothelium before emigrating into the interstitium and alveolar space. Selectin-mediated 
rolling of neutrophils and integrin-mediated arrest on the endothelium allows the 
neutrophil to extravasate through inter-endothelial junctions (Burns et al., 2003).  The 
intensity of neutrophil penetration is based on the chemokines and cytokines released at 
the primary sites of inflammation (Grommes and Soehnlein, 2010).  
During LPS-induced ALI, neutrophil infiltration into the alveolar lumen and 
interstitium and escalated numbers of macrophages in the thickened septa are the primary 
diagnostic histolopathologic abnormalities compared to lungs of normal animals with thin 
septal walls, occasional macrophages, and low number of neutrophils (Rittirsch et al., 
2008). Ultrafine carbon particles, which are major components of air pollutants, induced 
lung injury in mice and resulted in increased disruption of blood- gas barrier. Lungs 
treated with LPS and ultrafine carbon particles showed significant swelling, 
fragmentation and denuded basement membrane. Electron microscopy images showed 
the presence of ultrafine carbon particles in denuded basement membrane indicating their 
role in disintegration of basement membrane and establishment of pulmonary edema and 
swelling. Transport of ultrafine carbon particles from the blood-air barrier to the alveolar 
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lumen through denuded basement membrane, which in turn leads to acute lung injury 
(Inoue et al., 2009).  
Terminal ALI patients have lung histopathologic lesions characterized by 
progressive fibro-proliferative reactions by mesenchymal cell migration into the air 
spaces. Regulatory signals required for the migration is a set of proteins expressed on the 
air space area, which are exhibiting homology to PDGF.  The process of fibro-
proliferation is anatomically identical to the granulation reaction seen during wound 
healing (Snyder et al., 1991).  
Resolution of inflammation requires the effective removal of accumulated edema, 
phagocytosis of activated/dead inflammatory cells, and functional restoration of 
endothelial and epithelial barriers (Matthay et al., 2012). In addition, transforming growth 
factor (TGF)-β, produced by CD4+ CD25+ Tregs, influences the apoptosis of activated 
neutrophils at the site of injury and inhibits pro-inflammatory cytokine production by 
macrophages (DeAlessio et al., 2009). 
 
1.2.2 Pneumonia  
Pneumonia caused by bacterial, viral or fungal infections results in alveolar 
inflammation characterized by accumulation of cellular and inflammatory debris in the 
alveoli leading to clinical symptoms such as cough with phlegm, fever, and difficult 
breathing. Influenza A and respiratory syncytial virus are major contributors of viral 
pneumonia in humans (Marcos et al., 2009). Early data from the 1920s revealed increased 
mortality and morbidity due to bacterial infection in influenza patients  (Metersky et al., 
2012).   
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Streptococcus pneumoniae is a major causative agent for lower respiratory tract 
infection and subsequent bacterial pneumonia in children infected with Influenza virus. A 
significant portion of viral-bacterial co-pathogenesis could be prevented by bacterial 
vaccines (Madhi et al., 2004). S. pneumoniae cells encounter mucus secretions of nasal 
cavity immediately after the infection. Outer capsule of pneumococcus minimizes 
bacterial entrapment in the nasal mucosa, thereby allowing the pneumococci to access the 
epithelial layer. Immediately after infection, cells invaded by pneumococcal organisms 
are found within the glycocalyx layer of the respiratory and olfactory epithelium (Nelson 
et al., 2006).  
In S. pneumoniae infection, the TLRs essentially detect numerous PAMPs and 
induce an active innate immune response against the pathogen. S. pneumoniae infection 
triggers the innate immune system through both TLR2-dependent and independent 
pathways. TLR2 has been considered to regulate innate immune response to S. 
pneumoniae infection, through interaction with lipoteichoic acid, peptidoglycan, and the 
lipoproteins, which are elements found within bacterial cell wall. This recognition by 
TLR2 is critical activate the immune system to contain S. pneumoniae infection (Lee et 
al., 2007). Vos et al. reported that TLR2 is important in enhancing phagocytosis and 
oxidative killing of the S. pneumonia by the granulocytes (de Vos et al., 2015). TLR4 
also has a role in body’s innate immunity against S. pneumoniae infection. Recognition 
and interaction between the TLR4 and the pneumomolysin causes inhibition of growth of  
S. pneumoniae, especially in the nasopharynx colonization (Wilson et al., 2014).  
Depletion of alveolar macrophages in murine pneumonia model contributed to 
increased lung inflammation and inadequate clearance of apoptotic neutrophils (Knapp et 
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al., 2003). Additionally, depletion of alveolar macrophages led to a high occurrence of 
mortality due to the accumulation of necrotic or apoptotic cells in lung (Barnes, 2004). S. 
pneumoniae is detected by alveolar macrophage and can be internalized and processed to 
phagosomes, which progressively become phago-lysosomes. In immune-deficient 
individuals, phagocytosis of S. pneumoniae by alveolar macrophages is likely less 
effective than it is in immune competent individuals. But complement cascade-mediated 
S. pneumoniae phagocytosis and efficient processing to phago-lysosomes is reported in 
individuals with antibodies against the bacteria (Gordon et al., 2000).  
 
1.3 Innate immune system 
The innate immune system is the first line of defense in detecting and responding 
towards a pathogen invasion. It is composed of pathogen-associated molecular pattern-
recognizing receptors such as TLRs, NLRs and RIGs, and immune cells such as 
neutrophils and macrophages. Innate immune receptors not only detect the specific 
molecular patterns, but also trigger phagocytosis and activation of inflammatory 
pathways (Janeway and Medzhitov, 2002). The immune system is comprised of various 
immune cells such as neutrophils, macrophages, mast cells, natural killer (NK) cells, and 
dendritic cells (DCs). Two cell types and their role in innate immunity, which are the 
focus of this thesis, are described below.  
 
1.3.1 Neutrophils in innate immune system 
Neutrophils are innate immune cells that provide resistance for the host against 
various threats to the body, including microbial pathogens. Neutrophil precursors are 
produced and differentiate in the bone marrow. Once neutrophils mature, they are 
 8 
exported to the blood stream and are circulated until they undergo apoptosis and are 
removed from circulation by macrophages in the bone marrow, spleen, and liver (Mathias 
et al., 2006).  
In response to inflammatory stimuli, the neutrophils migrate towards the infected 
tissues and control the invading pathogens by producing proteolytic enzymes, 
antimicrobial peptides, and reactive oxygen species (Brinkmann et al., 2004). Neutrophils 
have both the oxygen-dependent and independent mechanisms to eliminate pathogens. 
The oxygen-independent mechanism involves the release of antimicrobial proteins and 
peptides into the phagosomes (Lehrer and Ganz, 1999). Oxygen-dependent mechanisms 
involve the production and release of potent antimicrobial free radicals produced by 
NADPH oxidase and myeloperoxidases (Serhan and Chiang, 2004). Neutrophils can 
release granule proteins and chromatin that forms an extracellular trap called neutrophil 
extracellular traps (NETs), capable of trapping and degrading virulence factors in bacteria 
(Brinkmann et al., 2004).  
Phagosomal membrane translocation of cytoplasmic oxidative enzymes during the 
neutrophil activation leads to the activation of NADPH oxidase, which in turn produces 
antimicrobial products such as superoxide. Activation of myeloperoxidase (MPO) 
catalyzes the production of hypochlorous acid and other secondarily derived reactive 
oxygen species (ROS) such as singlet oxygen and hydroxyl radicals. After the activation 
and internalization of the pathogen, neutrophils undergo spontaneous apoptosis in order 
to bring the immune system to homeostasis. Neutrophil apoptosis lead to the resolution of 
immune response (Amulic et al., 2012; Douda et al., 2014). 
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1.3.1.1 Neutrophil chemotaxis 
Chemotaxis, the guided movement of cells by chemical gradients created by 
chemoattractant proteins, such as chemokines and bacterial products produced at the site 
of inflammation, probably emerged early in eukaryotic evolution (Kay et al., 2008). 
Neutrophils are highly mobile cells that readily undergo chemotaxis. Neutrophils can 
detect as low as 1/100th of a chemokine gradient. They polarize their migration towards 
bacterial peptides over a pool of other chemical gradients to reach sites of inflammation. 
Neutrophils adopt a ‘pseudopodia- centered model’ to migrate towards the chemokine 
concentration gradient. Neutrophils undergo amoeboid-type movement, the most 
primitive form of single cell migration. Amoeboid-type of cell migration is characterized 
by rapid morphological changes with minimal substrate contact by the cell followed by 
high velocity migration (often 5-28µm/min) (Lammermann and Sixt, 2009). Neutrophil 
migration is mainly orchestrated by polymerization and depolymerisation of actin 
proteins (Arraes et al., 2006).  
Chemokines are cationic molecules that immobilize on endothelial surface with 
the help of anionic heparin sulphates. Chemokine distribution is concentration-dependent 
and, eventually, creates an intravascular chemokine gradient for neutrophil chemotaxis. 
Neutrophil chemotaxis begins with the phosphorylation and activation of specific G- 
protein coupled chemokine receptors on the neutrophil surface, which will result in a 
conformational change of surface integrin proteins. Binding between lymphocyte 
associated antigen (LFA) on neutrophil surface and intercellular adhesion molecules of 
endothelium induces a conformational change to talin-1, a cytoskeletal protein, leading to 
firm attachment and slow rolling of neutrophils (Wang et al., 2011).  
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Neutrophil recruitment to the site of inflammation follows specific steps: 
tethering, rolling, adhesion, crawling, and transmigration. The process of neutrophil 
chemotaxis is initiated by changes on the endothelial surface caused by pathogen-induced 
or tissue injury-mediated secretion of specific chemokines that are released from tissue-
resident innate immune cells (Kolaczkowska and Kubes, 2013). Endothelial cells can also 
be activated directly through their surface receptors recognizing specific pathogen 
associated patterns (PAMPs) or damage associated molecular patterns (DAMPs). Once 
activated, endothelial cells express specific adhesion molecules like P- and E-selectin on 
their surface. These selectin proteins play a crucial role in initiation and maximization of 
neutrophil recruitment to the site of injury (Sundd et al., 2011). Once expressed on the 
endothelial surface, selectins bind to their definitive ligands, such as P-selectin 
glycoprotein ligand 1, on the neutrophil surface leading to the slowing down of free 
moving neutrophils. L- selectin plays key role in accelerating the secondary tethering of 
neutrophils (McDonald and Kubes, 2011; Sundd et al., 2013). Eventually, neutrophils 
attach to endothelium while experiencing a shear stress of 10-100µN/cm2 (Halilovic et 
al., 2015). This rapid deceleration requires extensive manipulation of adhesive bonds 
between neutrophils and endothelial surface. The surface of neutrophils is covered with 
LFA, which binds to ICAM1 and ICAM2 on vascular endothelial membranes to allow 
the neutrophil to be tethered to the endothelium (Sanz and Kubes, 2012; Halilovic et al., 
2015).  
Activated and adhered neutrophils exhibit ‘pirouetting’ behavior as they begin to 
elongate pseudopodia and scan nearby areas while adhered to a location with the 
endothelium. During the adhesion stage, neutrophils prepare for transmigration by 
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crawling to endothelial cell junctions. The mechanotactic components of neutrophil 
crawling over the endothelium are orchestrated by many signals includes VAV1, a Rho 
family GTPase, and CDC42, a cell division regulator and regulator of actin during 
neutrophil polarization and migration. Actin binding protein, known as debrin-like 
protein (DLB), in association with β2 integrin proteins, induces conformational changes 
in the actin cytoskeleton of neutrophils (Futosi et al., 2013).  
Neutrophil transmigration from blood vessels to the injury site takes 
approximately 15- 20 min (2-5 min to cross the endothelium and 5-15 min to cross the 
basement membrane) (Muller, 2013). Along with ICAMs and integrins, neutrophils 
require adhesion molecules such as vascular cell adhesion protein-1, platelet/endothelial 
cell adhesion molecule 1, CD99, vascular adhesion protein 1, and leukocyte specific 
protein 1 (LSP1) to cross the endothelial barrier (Li Jeon et al., 2002). Neutrophils 
migrate to the site of injury either between two endothelial cells (paracellular migration) 
or through an endothelial cell (transcellular migration). Paracellular migration requires 
relaxation of endothelial cell junctions and is the most common mode of neutrophil 
migration. During transcellular migration, endothelial cells form ‘domes’ around adhered 
neutrophils by extending villi-like projections (Parkos et al., 1992).  Adhesion molecules 
such as ICAM1 and VCAM1 are abundant in domes, which actively interact with LFA-1 
and integrin α4 of neutrophils. LSP1, an actin binding protein expressed abundantly in 
endothelial cytoplasm and nucleus, regulates endothelial cell dome formation. This 
process is completely different from classical endocytosis because neutrophils never 
merge with the intracellular compartment of endothelium (Ley et al., 2007; Halilovic et 
al., 2015).  
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During the initiation of paracellular migration, cytoskeleton reorganization in 
endothelial cells enables them to alter their attachment of the extracellular matrix (ECM) 
via specific focal adhesions (Okun et al., 2009). The endothelial basement membrane is 
composed of a complex mesh-like ECM composed of proteins, such as laminin and 
collagen.  Neutrophils release proteases, such as MMPs and neutrophil elastase, to 
degrade ECM in order to ‘cut’ its way to the site of injury (Marki et al., 2015).  
Extracellular signal regulated kinases (ERK) and p38 are two MAP Kinase proteins 
playing crucial role in PMNs chemotaxis towards fMLP. Neutrophil movement towards 
fMLP gradient regulates via specific G protein coupled receptor, known as formyl 
peptide receptor (FPR). The fMLP-induced ERK regulated activity of G protein coupled 
receptor kinase 2 (GRK2) and inhibited neutrophil chemotaxis at escalated 
concentrations, whereas p38 acted as a non-canonical G protein coupled receptor kinase 
that phosphorylated FPR itself and activate neutrophil migration by arresting GRK2 
pathway at reduced concentrations (Arraes et al., 2006). 
 
1.3.1.2 Neutrophil apoptosis 
There are specific receptors, known as “death receptors” which can induce 
apoptosis.  These receptors are members of the tumor necrosis factor or nerve growth 
factor receptor super family or the Fas ligand receptors (Kennedy and DeLeo, 2008). 
Activation of death receptors results in initiation of the extrinsic pathway of apoptosis.  
However, Fecho and colleagues proposed that neutrophil apoptosis from Fas receptor or 
Fas ligand deficient mice appears to be normal, suggesting that extrinsic activation is 
unimportant in activating neutrophil apoptosis (Fecho and Cohen, 1998). Instead, 
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neutrophil apoptosis may be due to the internal signaling that activates the intrinsic 
pathway of apoptosis or another extrinsic signaling pathway that has not been identified.  
Spontaneous neutrophil apoptosis via the intrinsic pathway involves a change in balance 
among the members of the Bcl-2 family of proteins (Luo and Loison, 2008). Mcl-1 and 
A1 concentrations are upregulated by GM-CSF or LPS stimulation, inducing neutrophil 
survival. There are several distal proteins, for example caspase 3, caspase 8, and caspase 
9, that trigger proteolytic cascades that lead to the neutrophil apoptosis (Scheel-Toellner 
et al., 2004).  
There is some evidence suggesting neutrophil apoptosis through the extrinsic 
pathway of apoptosis. Fas is one of the important receptors that forms death-inducing 
signaling complex (DISC) and is expressed on the surface of neutrophils, as well as on 
virtually all other mammalian cells. Fas-associated death domain (FADD) is an 
intracellular domain through which Fas leads to accumulation of death domains on the 
cytoplasmic side of the cell membrane, which leads to the induction of caspase pathway 
and apoptosis (Scheel-Toellner et al., 2004).  TNF alpha-receptor, a transmembrane 
protein and a TNFR-associated death domain (TRADD) in the cytoplasmic region of the 
protein, also regulates apoptosis of neutrophils. It has been shown that intercepting TNFR 
activity using antibodies inhibits neutrophil apoptosis (Gon et al., 1996). Bianchi and 
colleagues shown that TNF-related apoptosis inducing ligand (TRAIL) also induces 
apoptosis in neutrophils.  There are five TRAIL receptors (TRAIL-R1, TRAIL- R2, 
TRAIL-R3, TRAIL-R4, and TRAIL-R5) that have been identified on neutrophil surfaces 
(Bianchi et al., 2006).   
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1.3.2 Macrophages in innate immunity 
Mononuclear phagocytic cells, such as macrophages and monocytes, are involved 
in neutralizing pathogens and maintaining tissue homeostasis by directing the 
inflammatory process, both through activation and resolution.  In mammals, monocytes 
contribute 4-10% of the total nucleated blood cell population and have a half-life in 
circulation of 20hr (Cavaillon, 1994). Monocytes originate in primary lymphoid organs, 
such as the bone marrow, from myeloid progenitor cells. Alveolar macrophages (AMs) 
are resident macrophage cells located within the alveoli of the lung.  They participate in 
pathogen recognition through PRRs, such as TLRs, NODs, and RIGs. Upon activation, 
AMs secrete pro-inflammatory cytokines such as IL-1β, TNF-α, IL-2, which in turn 
activate alveolar epithelial cells and endothelial cells and recruit of neutrophils (Herold et 
al., 2011; Balhara and Gounni, 2012). Additional monocytes are recruited to the lung in 
response to the release of monocyte chemotactic protein-1 (MCP-1) from pulmonary and 
inflammatory cells (Lee et al., 2008).  
When alveolar macrophages are depleted in mice infected with pneumococcus, 
inefficient clearance of necrotic and apoptotic neutrophils was observed and mice 
exhibited higher mortality compared to controls (Boyd et al., 2012). During LPS 
exposure, another macrophage population involved in the resulting inflammatory 
response in some species is pulmonary intravascular macrophages (PIMs). According to 
the functional analysis of PIMs vs AMs, PIMs are more aggressively phagocytic and 
cytotoxic than PAMs but are comparable in antibody-dependent cellular cytotoxicity. 
Analysis of effector cells showed that PIMs are less efficient or equal in cancer cell-lysis 
compared to PAMs (Chitko-McKown et al., 1991; Thanawongnuwech, 1998).  
Macrophages respond to the specific “find me” signals for example specific nucleotides 
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released though channels like pannexin 1 channels from apoptotic neutrophils. Soluble 
proteins such as pentraxins, ficolins, collectins secreted by innate cells and are 
collectively referred as bridging molecules since they involve in the molecular pattern 
recognition and response (Herold et al., 2011).  
 In general, macrophages are classified into two distinct subsets, namely M1 and 
M2. M1 macrophage subset is involved in killing or phagocytic functions, whereas the 
M2 subset is involved in healing or growth functions (Italiani and Boraschi, 2014). Based 
on the type of initial stimulus, macrophages use T cells to amplify their response effects 
along with polarizing into a M1 or M2 phenotype to generate a specific response. It is 
believed that macrophage-directed adaptive immune responses will be either M1/Th1 or 
M2/Th2. Because of immunological redundancy, innate immune system converts M1 to 
M2 or vice versa based on the requirement (Covarrubias et al., 2013). This inter-plasticity 
of M1 and M2 macrophage subsets are usually analyzed by recombinant Cre-lox system 
under iNOS or arginase promoters (Cassol et al., 2009). 
   
1.4 Toll-like receptors 
Microorganisms continuously challenge the host defense, which includes the 
innate, and the acquired immune systems with the innate system acting as the first line of 
immune defense (Akira and Takeda, 2004). The notion that there may be specific 
receptors for microbial molecules led to the identification of a group of proteins called 
Toll-like receptors (TLRs). TLRs are a family of evolutionarily conserved pathogen 
recognition receptors that play a critical role in innate immunity and in early response 
against invading pathogens (Akira et al., 2001). The protein Toll was first reported as a 
receptor involved in embryonic development of the fruit fly (Hashimoto et al., 1988) and 
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later, TLRs, designated as Toll’s mammalian homologues, were described (Medzhitov et 
al., 1997). TLR function was rapidly determined to be responsible for recognition of 
microbial invaders (Basu and Fenton, 2004). Thirteen TLRs (named TLR1 to TLR13) 
have been identified in humans and mice, and equivalent forms of many of these have 
been identified in other mammalian species. TLRs recognize extracellular and 
intracellular ligands consisting of a variety of microbial proteins and peptides, 
polysaccharides, proteoglycan, nucleic acids, and phospholipids (Liu et al., 2010). 
 
1.4.1 Ligands of TLRs   
Each TLR recognizes specific PAMPs derived from various microorganisms 
including bacteria, viruses, protozoa and fungi (Akira et al., 2006). In addition to 
microbial PAMPs, an escalating number of endogenous molecules are reported as 
candidate ligands of TLRs (Chiron et al., 2008). The main endogenous molecules that 
activate TLRs are fibronectin, heparin sulphate, biglycan, fibrinogen, oligosaccharides of 
hyaluronan, and hyaluronan breakdown fragments (Ian R. Rifkin, 2005; Yu et al., 2010). 
In pathological conditions, these endogenous molecules are secreted by inflamed/dying 
cell or by activated cells in a non-conventional lysosomal-dependent manner (Pollanen et 
al., 2009). These endogenous ligands act as alarms and give early warning signals to 
innate and adaptive immune systems (Liu et al., 2010). 
 TLR2 and TLR4 are the principal receptors involved in the recognition of various 
bacterial cell wall components. TLR4 is crucial for effective responses to LPS, a 
component of Gram-negative bacterial cell walls (Hong-Geller et al., 2008). Recognition 
of LPS, part of bacterial cell membrane, by TLR4 requires a concerted effort by 
additional molecules including LBP (LPS Binding Protein), CD14, and MD2. Integrin 
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CD11b/CD18 also play a role in TLR signaling towards LPS stimulus and these 
molecules provide negative feedback mechanism to limit the TLR action during long-
term LPS signals (Han et al., 2010). TLRs3, 7, and 8 play important roles in responses to 
viruses. Double-stranded viral RNA activates TLR3 while TLRs7 and 8 are activated by 
single-stranded RNAs (Albrecht et al., 2004). TLR9 plays an important role in detection 
of CpG DNA present in bacteria and viruses (Lund et al., 2003). Bacterial flagellin 
proteins are recognized by TLR5.  TLR1 is responsible for the detection of triacyl 
lipopeptides (Aboussahoud et al., 2010). 
 
1.4.2 TLR signaling 
TLR signaling is initiated by dimerization of TLRs, which can form homodimers 
(such as TLR4) or hetero-dimers (such as TLR2 and TLR1). Other than TLR3, all the 
TLRs using MyD88 as primary adaptor molecule to initiate the signaling cascade (Akira 
and Takeda, 2004). After ligand binding, TLRs/IL-1Rs domain, dimerize and undergo the 
conformational change required for the recruitment of downstream signaling molecules. 
These include the adaptor molecules myeloid differentiation primary-response protein 88 
(MyD88), IL-1R-associated kinases (IRAKs), transforming growth factor-β (TGF-β)-
activated kinase (TAK1), TAK1-binding protein 1 (TAB1), TAB2 and tumor-necrosis 
factor (TNF)-receptor-associated factor 6 (TRAF6). The TLR signaling pathways follow 
two types of downstream activation, MyD88-dependent and MyD88-independent 
pathways, which eventually switch on the pro-inflammatory cytokine response through 
NF-κB and AP1 up-regulating nuclear transcription (Akira, 2003). TLR3 utilizes a TIR-
domain-containing adapter-inducing interferon (TRIF) dependent pathway that ultimately 
ends in up-regulation of interferon pathway.  The activation of TRIF TLR4 utilizes TRIF-
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related adaptor molecule (TRAM) as a “bridge molecule” to activate TRIF. The 
activation of IRF by TLRs via MyD88 or TRIF leads to the production of type I 
interferon (Sabroe et al., 2008).  
 The stimulus induced dimerization of the receptors’ extracellular domains leads 
to coordinated conformational changes that, in turn, lead to self-association or 
reorganization of the cytoplasmic domain- TIRs, thereby creating a new molecular 
docking site for the recruitment of signaling adaptor molecules. In the model of the TLR4 
homodimer proposed by Miguel and colleagues, the interface has significant interactions 
involving the BB loops, a loop which connects second β-strand and a second helix 
includes a proline residue, of the two subunits. Proline residues give the normal and rigid 
conformation of the BB loop and the replacement or substitution of these residues will 
result in the internal homodimer geometry distortion (Miguel et al., 2007). The TIRs offer 
a rotational flexibility to the linkers with the 2- fold axis symmetry of the receptors. 
TLR4 homodimer forms a flat, slightly curved architecture to make a top or membrane 
proximal surface of the structure (Deng et al., 2013). Upon ligand activation, TLR2 can 
form heteromers with TLR1 or TLR6 (Farhat et al., 2008).  
 
1.4.3 TLR cellular localization 
TLRs actively localize to different cytoplasmic compartments depending on their 
functional properties. TLR4, one of the five human TLRs showing orthology with Toll of 
Drosophila, is a membrane-spanning protein that binds with LPS. TLR4 is normally 
localized to plasma membrane and Golgi complex in resting human monocytes (Shi and 
Kehrl, 2010). It is associated with CD14 and MD2 protein, which help in the 
translocation of TLR4 to the cell surface (Togbe et al., 2007). The presence of TLR4 has 
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been observed in the cytoplasm and nucleus of pulmonary intravascular macrophages and 
septal endothelial cells in normal and inflamed cells (Schneberger et al., 2010). It has 
been proposed that the whole complex of TLR4-CD14-MD2 cycles to Golgi complex and 
recycles rapidly (Latz et al., 2002). The internalization process of TLR4-LPS complex is 
observed within 15 min after ligand activation and is mediated by clathrin and dynamin. 
Endosomal internalization of TLR4 complex is considered to be one of the negative 
regulatory pathways to limit TLR4 signaling and an ubiquitination step leads to 
degradation of the TLR4 (Palsson-McDermott et al., 2009). TLR4 is localized in the 
Golgi complex and not on the plasma membrane in m-ICc12 cell line (Mathias W. 
Hornef et al., 2002).  
 On the other hand, TLR2 has been identified in early and late endosomes, but not 
in the Golgi complex or endoplasmic reticulum. TLR2 forms a heterodimer along with 
TLR1/6. CD14 and CD36 are the co-receptors of the TLR2- TLR1/6 heterodimer 
complex. Activation of type 1 IFN pathway, but not TNF-α production, demands the 
internalization of TLR2. This demonstrates that TLR2 can activate two different 
signaling pathways from two different locations (Barbalat et al., 2009).  
TLR3, 7, and 9 have specific retention signals that localize them to the Golgi 
complex and prevent translocation to cell membrane to prevent inadvertent activation of 
intracellular TLRs (especially TLR9) by nucleic acids of self-origin. For TLR9, either its 
transmembrane region or transmembrane sequence is efficient for its retention in the 
Golig comprex (Leifer et al., 2006). The intracellular TLRs move to endosomes after 
activation by their respective ligands (Barton et al., 2005).  Taken together, there is 
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diversity in the localization of TLRs in various cells, but further works needs to be 
performed to further evaluate TLR expression and localization in all cell types.   
 
1.4.4 Cross expression of TLRs 
Though each TLR has a highly specific ability to recognize a particular microbial 
pattern, recent papers suggest that some ligands are able to activate the expression of 
TLRs in addition to their traditional assigned specific receptor. Elevated TLR mRNA and 
protein expression in response to stimulation with cytokines, pathogenic organisms, and 
cases of mucosal inflammation have been reported (Fan, 2009). Cells treated with TLR4 
ligands showed increased expression of TLR5, 7 and 9 in STC-1 and RAW 264.7 (Ghosh 
et al., 2007). Similarly increased expression of TLR2 and TLR4 occurred in the presence 
of PAMPs other than LPS on submucosal macrophages in inflamed mucosa. In the 
presence of Pam3CSK4, which is the ligand of TLR1/2, TLR5 was found to be strongly 
upregulated (Ozinsky et al., 2000). Later studies proved that the presence of Pam3CSK4 
stimulates the binding of TLR2 with TLR1 and influences TLR5 up-regulation (Barbara 
Koller, 2008). We have previously shown that TLR2 and TLR9 expression is increased in 
the lungs of horses following intravenous exposure to E. coli LPS, which is a ligand for 
TLR4 (Singh Suri et al., 2006; Schneberger et al., 2011). Ligands of TLR2 or 4, in 
combination with TLR7/8, up-regulate the expression of IFN-γ, IL-12, and IFN-α 
expression in human peripheral blood mononuclear cells (Ghosh et al., 2007).  There is a 
great need for clarity on the expression of individual TLRs following the ligation of 
another single TLR or simultaneous ligation of multiple TLRs by their respective ligands. 
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1.4.5 Toll-like receptor 10 
TLR10 is recently identified TLR whose ligand and signaling pathway is still 
unknown. It is expressed in a variety of organs including lymph nodes, spleen, thymus, 
and lungs (Chuang and Ulevitch, 2001). Functional TLR10 is absent in mice and no 
model organisms have been identified thus far.  Studies in chickens confirm the presence 
of ten TLRs (TLR1- 10) with gene expression patterns being homologous to mammalian 
systems (Chuang and Ulevitch, 2001).  
 
1.4.5.1 Structure 
Human TLR10 is the most recently identified TLR protein.  It encodes 811 amino 
acids and has a molecular mass 95 kDa. TLR10 is a 3269 bases gene in chromosome 4 
and the protein consists of a conventional leucine cysteine rich domain and a cytoplasmic 
toll interleukin-1 receptor domain. TLR10 shows homology with other TLRs in their 
structure with a signaling peptide (1-19 amino acids), which leads to protein for its 
membrane translocation. The location of the cysteine residues within the amino acid is at 
526, 528, 553, and 574 (Chuang and Ulevitch, 2001). TLR10 exhibits 50% homology 
with TLR1, 49% with TLR6, and 30% with TLR2. A 13 amino acid signaling sequence 
located in the C-terminal of TLR2, which is involved in TLR2 down-regulation, is also 
present in TLR10.  Because of this homology, TLR10 may follow a similar type of 
downstream signaling after activation (Lazarus et al., 2004). Guan et al proposed triacyl 
lipopeptides mediated activation and dimerization of TLR10 with TLR2 through an 
alternative pathway of TLR2 activation (Guan et al., 2010).  
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1.4.5.2 TLR10: Evolutionary aspects  
Sequence analysis and phylogenetic mapping have grouped vertebrate TLRs into 
six ‘gene families’- namely TLR1, TLR3, TLR4, TLR5, TLR7, and TLR11. Generally in 
vertebrates, each TLR family is encoded in a single gene but the TLR1 super family 
shows exception with TLR1, TLR2, TLR6, and TLR10 being encoded by multiple genes. 
This gene cluster stably evolved and is conserved by high positive purifying selection 
(Calvano et al., 2005). Two evolutionarily conserved forms of TLR5 in rainbow trout 
show evolutionary analogy of mammalian TLRs (Rebl et al., 2010). 
 Independent gene duplication was observed in the TLR1 family, both in avian 
and mammalian systems. Gene conversion of the human TLR1 family occurred 42-44 
million years ago in the common primate ancestor of human, chimpanzee, orangutan, and 
rhesus monkey. There are two orthologous groups of TLR1 family that were present in 
mammals and avian as TLR1A/TLR10 and TLR1B/TLR1/TLR6, which might be the 
product of gene duplication that occurred about 360 million years ago. Computational 
modeling of the TLR10/TLR2 heterodimer indicates the presence of a lipopeptide 
binding pocket, which shows homology to the binding sites in the TLR1/TLR2 complex 
(Huang et al., 2011).  
 
1.4.5.3 TLR10 in Cell Signaling 
Hypoxia induces the up-regulation of TLR10 in a human monocyte cell line, 
THP-1 (Kim et al., 2010). The hypoxic condition in this model was designed to mimic 
low oxygen conditions that occur during bacterial infection or tissue injury. Systemic 
hypoxia induces production of reactive oxygen species (ROS), which up-regulates the 
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pro-inflammatory transcription factors, such as NF-κB and AP-1, which in turn up-
regulate TLR10. Luciferase binding assays indicate a potential NF-κB binding site in 
TLR10 gene sequence (Kim et al., 2010). TLR10 mRNA expression was found in early B 
cell development and its translation was mainly observed during B cell differentiation 
(Bourke et al., 2003).  TLR10 dimerization was predicted to occur during its activation 
with the predictions ranging from 100% for a TLR10 homodimer, 87% for a TLR1 
complex, and 80% for a complex with TLR1/2. Accordingly, TLR10 is suspected to 
signal through the MyD88-dependent pathway to initiate the NF-κB nuclear translocation 
(Hasan et al., 2005). Increased expression of TLR10 and subsequent activation of 
interferon 1 signaling when dendritic cells were challenged with viral agents indicates the 
probable ligand for TLR10 may be viral in origin (Nyman et al., 2008). Co-localization 
of TLR10 with TLR2 in early phagosomes of activated macrophages suggests that 
TLR10 may use TLR2 as its co-receptor for its activation and signaling. Extracellular 
domains of TLR10 and TLR2 were found to be physically interacting with each other in a 
ligand dependent manner (Guan et al., 2010).  
 
1.4.5.4 TLR10 polymorphisms and disease susceptibility 
Genetic variations in TLR10 gene may play a critical role in human asthma, as 
there were 78 single nucleotide polymorphisms of the TLR10 gene discovered in 47 
samples from asthmatics of comprised of multiple USA ethnic groups.  The single 
nucleotide polymorphism (SNP) frequency was five in the European American group and 
twenty-three in the African American ethnic group. It is also proposed that the 
association of these two independent samples and phenotypes provides high susceptibility 
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for asthma (Lazarus et al., 2004; Tizaoui et al., 2015). Since TLR6 and 10 are found on 
same chromosome with a 58kb distance apart, it is difficult to differentiate the 
independent role of TLR6 and TLR10 polymorphism in asthmatics using current 
molecular marker techniques. Two polymorphisms in TLR6 gene and seven in TLR10 
gene were mapped from 322 patients suffering from clinical asthma (Lazarus et al., 
2004). TLR10 polymorphisms have also been identified in patients with nasopharyngeal 
carcinoma patients, demonstrating a potential role of TLR10 in cancer biology. TLR10 
polymorphism has been observed in prostate cancer patients.   Chen et al suggested that 
the TLR1-TL6-TLR10 gene cluster polymorphism might increase the risk of developing 
prostate cancer (Chen et al., 2007).  
Out of ten TLRs present in the humans, TLR10 has been recently identified and is 
the only “orphan” receptor, with no confirmed ligand or signaling pathway. Studies have 
shown that variation in the TLR10 gene might affect the occurrence of disease conditions 
such as asthma, nasopharyngeal carcinoma, and prostate cancer. The presence of TLR10 
in immune cells such as macrophages and neutrophils indicates a potential, but unknown, 
role in the detection of PAMPs and activation of innate immunity.  
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CHAPTER 2: HYPOTHESES AND OBJECTIVES 
 
2.1 Hypotheses  
1. TLR10 is expressed in the lungs and its expression is altered during inflammation.  
2. TLR10 is expressed in human neutrophils and LPS alters its spatial-temporal 
expression. 
3. TLR10 plays a role in neutrophil chemotaxis towards fMLP. 




1. To characterize and compare the expression profiles of TLR10 in normal and 
inflamed lung tissues of cattle, chicken, pig, rat and dog 
2. To characterize the expression and localization of TLR10 in control and LPS 
activated human neutrophils 
3. To study the role of TLR10 in neutrophil chemotaxis  
4. To study TLR10 expression in human macrophages 





Lungs are the largest and significant component of respiratory system with both 
respiratory and non-respiratory functions. Lungs are the sites for gas exchange and 
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involved in key physiological functions. Since lungs continuously interact with outer 
environment, they are the major sites of bacterial, viral or fungal infections leading to 
acute and chronic inflammatory diseases (Marsland and Gollwitzer, 2014). The diseases 
of respiratory system affect millions of people and livestock around the world, and cause 
significant mortality, morbidity and economic losses. Apart from infectious agents, 
physical agents such as cigarette smoke, environmental pollution, as well as genetic 
factors contributes to lung inflammation (MacNee, 2005).  
Infectious agents express highly conserved molecular patterns, which are 
recognized by innate immune receptors such as TLRs of the host immune system. 
Activation of innate immune receptors alerts the immune system to induce 
proinflammatory responses such as cytokines secretion, and activation of immune cells 
such as neutrophils and macrophages (Akira et al., 2006). There are a total of 13 TLRs 
that recognize specific ligands associated with various pathogens. TLR10 is the recently 
identified TLR family protein and to date, there are no data available about the ligand, 
signaling pathway and role in inflammation. Hence, it is refereed to as an “orphan 
receptor” (Janeway and Medzhitov, 2002).  
Recent data on the roles of TLR10 in immune response to viral and bacterial 
infection points towards its functional importance. Genetic polymorphisms in TLR10 
gene make individuals susceptible to chronic inflammatory diseases including asthma, 
and COPD (Tizaoui et al., 2015).  Currently, there are no data on the cell specific 
expression of TLR10 in the lung. Because the inflammatory processes are driven through 
coordinated actions of a variety of cells, it is important to understand the in situ 
expression of TLR10 in mammalian lungs. Because of the role of neutrophils as primary 
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effector cells in acute inflammation, I propose to examine the expression of TLR10 in 
normal and activated neutrophils, and design experiments to understand the role of 
TLR10 in neutrophil biology. Furthermore, the role of TLR10 in handling of bacteria 
such as S. pneumoniae is not understood. Therefore, I designed experiments to obtain 
data to fill gaps in our knowledge related to the biology of TLR10.  
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3.1 Abstract  
Toll-like receptors (TLRs) are conserved immune receptors that play critical roles 
in innate immunity and are known as “gate keepers” of immune system. TLR10 is 
identified as type 1 plasma membrane protein but the identity of its ligand remains 
unclear. Till date, no data are available on tissue and cell specific expression of TLR10 in 
normal and inflamed lungs of domestic animal species, and rat, which is commonly used 
as a model to study human diseases. We characterized a commercially available TLR10 
antibody for use in cattle, pig, dog, chicken, and rat. Western blotting of total lung protein 
extracts from cattle, dog, pig and chicken showed a band of 95kDa, which is similar to 
the molecular weight of TLR10. The immuno-histochemical and immuno-electron 
microscopic data show TLR10 expression in vascular endothelium and smooth muscles 
in lungs of control and inflamed animals. Further, we found that expression of TLR10 in 
bovine neutrophils is altered upon treatment with E. coli lipopolysaccharide. These data 
show TLR10 expression in the lungs of these mammalian species and that activation of 










Toll-like receptors are members of the innate immune system and recognize 
pathogen associated molecular patterns (Takeda and Akira, 2004). Since the 
identification of Toll proteins in Drosophila, more than 10 TLR proteins have been 
identified in mouse and humans (Anderson et al., 1985; Hashimoto et al., 1988). These 
TLRs recognize microbial molecules such as lipopolysaccharides and initiate cell signals 
to activate immune cells and initiate inflammation. The functions of some of the TLRs 
such as TLR4, TLR2, and TLR9 have been studied extensively and point to their critical 
roles in organ pathophysiology (Andonegui et al., 2003; Dubourdeau et al., 2006).  
However, the data on some of the TLRs including TLR10 are scarce.  
TLR10 is expressed in immune cells such as neutrophils, macrophages, dendritic 
cells, organs such as spleen, thymus, and at lower levels in lungs of humans (Chuang and 
Ulevitch, 2001). The expression of TLR10 mRNA was reported in early B cell 
development and the translation commitment mainly observed during B cell 
differentiation (Bourke et al., 2003). While TLR10 is nonfunctional in mice due to 
several retroviral insertions, it is functional in avian system (Brownlie and Allan, 2010). 
Although the role of reactive oxygen species induced during hypoxia in upregulation of 
TLR10 mRNA in THP-1 cell line has been shown recently (Kim et al., 2010), there is yet 
no firm information on the identity of the ligand of TLR10.  
Domestic animals are susceptible to many bacterial lung diseases and these 
respiratory diseases inflict heavy economic losses on animal industry through morbidity 
and mortality. In USA, Mannheimia haemolytica infections, despite development of 
vaccines and better management strategies, cause more than $1.1 billion economic loss to 
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cattle and sheep industry (Sathiamoorthy et al., 2011). In dogs, Bordetella bronchiseptica 
is a commonly occurring infection, and it causes lung disease (Goodnow, 1980). 
Pulmonary infections caused by pathogens such as Porcine Reproductive and Respiratory 
Syndrome Virus as well as Haemophilus somnus and Actinobacillus spp. cause 
significant mortality and morbidity in pigs (Chiers et al., 2002). Over the recent years, 
there have been advances in understanding the expression and biology of TLRs in 
domestic animal species. We have contributed data on the expression of TLR4 and TLR9 
in normal and inflamed lungs of cattle, horses, pigs, and dogs (Wassef et al., 2004; Singh 
Suri et al., 2006; Schneberger et al., 2011). For example, TLR4 and TLR9 expression is 
altered in inflamed lungs of horses (Wassef et al., 2004). During these studies, we also 
found that pulmonary intravascular macrophages (PIMs), a population of macrophages 
unique to ruminants, equines and pigs, express TLR4 and TLR9 and their depletion leads 
to significant reduction in the amounts of TLR4 and TLR9 mRNA in lungs (Singh Suri et 
al., 2006; Schneberger et al., 2009). However, there are no data on the localization of 
TLR10 in lungs of domestic animal species. 
 Here we investigate the expression of TLR10 in lungs of pig, cattle, dog, rat, and 
chicken at tissue and subcellular levels using immuno-histochemistry, immuno-electron 
microscopy, confocal microscopy, and western blotting. We analyzed the changes in 
TLR10 expression on infection with M. haemolytica in cattle, Foal Adenovirus in chicken 
and H3N2 virus in pigs. Our data show that TLR10 is expressed in vascular endothelium 
and alveolar septa and the infection alters its expression in lungs of all the species.  
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3.3 Materials and methods 
3.3.1 Animals  
Research Ethics Committee of University of Saskatchewan approved all animals 
and protocols used in this experiment. Lung samples from chicken (n=8), cattle (n=5; 6 
weeks old; male; Holstein-Friesian breed), pig (n=5; 6 week old male), dog and rat (n=5) 
were harvested, fixed 4% paraformaldehyde and embedded in paraffin for routine and 
immuno-histochemical studies. Male calves were infected intra-tracheally with M. 
haemolytica (n=7; 6 weeks old; Holstein-Friesian breed; total dose 20x109 M. 
haemolytica/ calf) and pigs (n=6; 6 week old male) were infected with influenza A/ 98 
(H3N2) TX98 strain (total dose of H3N2 ~105 pfu) and euthanized at 24hr after the 
infections. Chickens were challenged with E. coli (107 cfu/bird) and FAdV (104 
TCID50/bird; n=6 each) and euthanized 24hr post-infection. Lastly, rats (n=8) were 
challenged intratracheally with E. coli lipopolysaccharide (1.5 µg/kg) 18hr prior to 
euthanasia.  Tissues were embedded in paraffin for light microscopy and in LR White for 
immuno-electron microscopy. Lung tissues collected in liquid nitrogen and frozen later 
were used for western blotting.  
 
3.3.2 Western blotting   
Frozen lung tissues were lysed and homogenized in 200µl freshly prepared lysis 
buffer composed of 150mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate, 
0.1% sodium dodecyl sulfate (SDS), 50mM Tris (pH 8.0), 5mM ethylene-diamine-tetra-
acetic acid (EDTA), and protease inhibitor cocktail (100µl/10ml; Sigma-Aldrich). Protein 
fraction collected were separated in 10% SDS-PAGE and transferred to Hybond-ECL 
nitrocellulose membrane (GE Healthcare, Mississauga, CA). Membrane was blocked for 
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nonspecific binding by 5% skim milk in 1X PBS for 1hr. The membranes were incubated 
with primary TLR10 antibody (1:600, 1mg/ml; Abcam, Cambridge, USA) for 12hr at 
4°C followed by treatment with HRP conjugated anti-goat IgG secondary antibody 
(1:1000, Dako, Ontario, Canada), and color development (GE Healthcare Inc.). Blots 
were scanned digitally and unbiased contrast adjustments were done.  
 
3.3.3 TLR10 immuno-histochemistry  
Paraffin-embedded tissues from chicken, cattle, pig, dog, and rat were used for 
immunohistochemistry. Paraffin sections were deparaffinized and rehyderated before 
antigen retrieval with pepsin (2mg/ml) treatment for 45min and endogenous tissue 
peroxidase quenching with 0.5% hydrogen peroxide in methanol for 30min. The sections 
were incubated with 1% BSA in 1X PBS for one hour followed by exposure to TLR10 
primary antibody (1:150, 6.67µg/ml) for one hour and HRP-conjugated anti-goat IgG 
(1:150) for 45min. The color development was carried out with a commercial color 
development kit (Vector Laboratories, Ontario, Canada). The controls included omission 
of primary antibody, incubation with isotype-matched antibody and the use of a peptide 
to block the binding of TLR10 antibody. We obtained custom-made 32 amino acid 
blocking peptide (Sequence: CHNRIQQLDLKTFEFNKELRYLDLSNNRLKSV) from 
New England Peptide (Gardner, MA, USA). Blocking peptide was dissolved in 1X PBS 
(pH 7.2; Concentration: 200µg/ml). We used 14µg/ml of the blocking peptide to block 
TLR10 polyclonal antibody. In brief, TLR10 antibody was diluted (1:150) in 1% BSA (in 
1X PBS) and added the blocking peptide (final concentration: 14µg/ml). The primary 
antibody-blocking peptide mixture was incubated for 2hr at room temperature. Immuno-
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histochemistry was performed, using this blocking peptide- antibody mixture, as 
explained above.  	
 3.3.4 Immuno-gold electron microscopy 
Lung tissues from cattle, dog, pig, and rat were embedded in LR White. Ultrathin 
(100nm) sections were prepared and placed on nickel grids. The sections were blocked 
with 1% serum albumin for 30min and incubated with TLR10 primary antibody (1:30) 
for one hour followed by exposure to gold-conjugated anti-goat secondary antibody 
(1:100; Fitzgerald Industries International, Concord, USA) for one hour. Negative control 
was performed by omitting primary antibody from the protocol.  
 
3.3.5 Confocal microscopy 
Isolated bovine neutrophils were incubated at 37°C and 5% CO2 in RPMI-1640 
with 10% fetal bovine serum and were treated with E. coli LPS (1µg/ml) for 60min. 
Neutrophils were fixed in 4% paraformaldehyde and permeabilized with 0.01% Triton 
X100. Nonspecific antigens were blocked by 5% BSA and Fcγ blocking was performed 
as previously described. Neutrophils were incubated with TLR10 antibody (1:250) one 
hour followed treatment with FITC-conjugated secondary antibody for 30min at room 
temperature. Cells were mounted in a medium containing DAPI and left overnight for 
proper conditioning of the slides for imaging. Confocal microscopy was performed in 
Leica TCS SP5 system (Leica Microsystems, Germany) with 63X oil immersion lens. 
 
3.3.6 Statistical Analyses  
Results are represented as Mean + SEM of three replicates. One-way ANOVA 
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was used for the comparison between the groups and p values with 0.05 or less than 0.05 
was considered significant. GraphPad Software (Avenida de la Playa, CA, USA) was 
used for all the analysis. 
 
3.4 Results 
3.4.1 TLR10 gene sequence alignment and protein expression in lung 
Commercial TLR10 antibodies are not available specifically for cattle, dog, pig, 
and chicken. Therefore, we compared the sequence of human TLR10 peptide used to 
raise a commercial antibody with the TLR10 sequence of cattle, pig, dog and rat. 
According to the manufacturer, the anti-human TLR10 antibody was raised against a 
synthetic peptide of 32 amino acids corresponding from 80-111 of human TLR10 (Fig.3. 
1A). The FASTA sequence of human TLR10 (GenBank Accession No. NM_030956) 
retrieved from NCBI was aligned against cattle (GenBank Accession No. 
NM_001076918), domestic pig (GenBank Accession No. NM_001030534), dog 
(GenBank Accession No. NM_001173127) and rat (GenBank Accession No. 
NM_001146035), using Clustal-W (EMBL-EBI, Cambridge, UK). The results indicated 
that the human TLR10 peptide used to generate the antibody had a homology of 71% 
with rat, 82% with dog, and 80% with both cattle and pig TLR10 proteins.  
3.4.2 Western blots for TLR10 
Western blotting of total lung protein extracts showed a band in 95 kDa region, 
indicating the expression of TLR10 protein in cattle, dog, and pig (Fig. 3.1B). The 
densitometric analysis (Fig. 3.1C) showed increased TLR10 expression in M. 
haemolytica infected cattle but not in influenza-infected pigs compared to their respective 
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controls. To analyze the changes in TLR10 expression during combined bacterial and 
viral infection, we performed the western blots with total lung protein isolated from 
chickens infected with E. coli and foal adenovirus (Figure 3.2A). We used densitometry 
to compare the expression of TLR10 between the normal and inflamed lungs. TLR10 
expression was found significantly (P<0.05) increased in lungs from all infected chickens 
compared to the controls (Fig. 3.2B).    
3.4.3 Expression and localization of TLR10 in normal and inflamed lungs 
Lung sections from cattle (Fig. 3.3A), rat and dog (data not shown) stained with 
isotype-matched antibody showed no staining. The specificity of TLR10 antibody was 
further established by lack of staining in sections that were incubated with blocking 
peptide-antibody mixture (Fig. 3.3B). The lung sections reacted with von Willebrand 
Factor (vWF) (Fig. 3.3C), a vascular endothelial antigen, delineated the vascular 
endothelium. 
TLR10 staining of control calf lung indicated the expression of the receptor in 
sub-epithelial area of bronchioles and sub-endothelial area of blood vessels (Fig. 3.3D). 
We observed TLR10 positive staining in alveolar septa as well. The TLR10 staining was 
much reduced in the M. haemolytica infected animals (Fig. 3.3E) compared to the 
controls.  
TLR10 staining in a control pig lung was observed in sub-epithelial areas of 
bronchioles (Fig. 3.4A). The TLR10 staining is apparently increased in lungs from pigs 
infected with swine influenza virus (Fig. 3.4B) and increased positive staining noted in 
bronchial cartilage (asterisks in Fig. 3.4B). Alveolar septa in lungs from control pigs (Fig. 
3.4C) showed negligible staining compared to those in lungs of infected pigs (Fig. 3.4D).  
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TLR10 staining in a control rat lung is seen in bronchioles but nearly absent in alveolar 
septa (Fig. 3.5A). Lung section from a rat treated with E. coli LPS shows much increased 
staining for TLR 10 in apical parts of bronchial epithelial cells, sub-epithelial areas (Fig. 
3.5B), and alveolar septa (Fig. 3.5C).   
Three sections from chicken lung show staining for von Willebrand Factor (Fig. 
3.6A), alpha-smooth muscle actin (Fig. 3.6B) and TLR10 (Fig. 3.6C) in a blood vessel.  
They show presence of TLR10 in perivascular space while faint staining is noticed on the 
endothelial surface. In contrast, vWF and alpha-smooth muscle actin mainly reacted with 
endothelium and vascular smooth muscle, respectively. 
We determined the fine localization of TLR10 in calf and pig lungs using 
immuno-electron microscopy. An electron micrograph of cattle lung shows TLR10 
staining in alveolar epithelium, vascular endothelium, and cytoplasm, and nucleus of a 
pulmonary intravascular macrophage (Fig. 3.7A). Alveolar macrophages (Fig. 3.7B) also 
showed TLR10 staining in plasma membrane, nucleus and cytoplasm. TLR10 is also 
localized on the luminal surface and cytoplasm of lung capillary endothelial cells (Fig. 
3.7C).  
 
3.4.4 TLR10 expression in bovine neutrophils 
We used isolated bovine neutrophils to further clarify the expression of TLR10 in 
these cells. Confocal microscopy of bovine neutrophils showed TLR10 on the plasma of 
normal neutrophils (Fig. 3.8). The TLR10 expression was increased especially in the 













































































Figure 3. 1: TLR10 amino acid sequence comparison and TLR10 western blots 
The comparison of human TLR10 amino acid sequence (Figure 1A) used for generating 
TLR10 antibody shows 80% homology with cattle and pig, 82% with dog, and 71% with 
rat corresponding to that detected by the antibody used. Figure 1B shows western blots 
from lung homogenates from cattle, pig, and dog. Each of the species shows a band of 
95kD, which corresponds to the molecular weight of TLR10. The data showed significant 
increase in TLR10 expression lungs of calves infected with M. haemolytica compared to 












Figure 3. 2: Lung inflammation upregulated TLR10 expression 
 (Figure 2A) Immunoblot of lysates from control and infected chicken lungs show 95KDa 
protein bands corresponding to molecular weight of TLR10. Lane1: Control; Lane 2: E. 
coli infection; Lane 3: E. coli + IBDV infection; Lane 4: FAdV infection; Lane 5: FAdV 
+ IBDV infection. Densitometric quantification (Figure 2B) showed significant increase 







Figure 3. 3: Immunohistochemistry of normal and inflamed calf lungs 
Lung section from control cattle stained with isotype-matched antibody (Figure 3A) lacks 
staining. Figure 3B shows lack of staining a pig lung section where a blocking peptide 
was used in the protocol whereas the one stained with vWF antibody (Figure 3C) shows 
staining in endothelium (arrows) but not in bronchiolar epithelium. Lung section from a 
control animal (Figure 3D) shows staining (arrows) in sub-epithelial area of a bronchiole 
and sub-endothelial area of a blood vessel. Alveolar septa (thick arrows) also show 
TLR10 staining. The TLR10 staining is much reduced in a lung from a calf infected with 














Figure 3. 4: Immunohistochemistry of normal and inflamed pig lungs 
Figure 4A shows TLR10 staining (arrows) in a control pig lung is observed in sub-
epithelial areas of a bronchiole. The TLR10 staining (Figure 4B) is apparently increased 
in a lung from pig infected with influenza A. TLR10 positive staining was observed in 
the bronchial cartilage (shown in asterisks). TLR10 staining (Figure 4C) in the alveolar 
septa in control animals is negligible compared to those from the infected pigs (Figure 















Figure 3. 5: Immunohistochemistry for rat lungs 
TLR10 staining (Figure 5A) in a control rat lung is seen in a bronchiole but nearly absent 
in alveolar septa. Section from a lung from a rat treated with E. coli LPS shows staining 
in bronchial epithelial cells (arrows), sub-epithelial areas (asterisks) in figure 5B and 







Figure 3. 6: TLR10 staining in perivascular area of blood vessel 
Three sections from chicken lung show staining (arrows) for von Willebrand Factor 
(Figure 6A), alpha-smooth muscle actin (Figure 6B) and TLR10 (Figure 6C) in a blood 
vessel (V).  The sections show TLR10 mainly in perivascular space while faint staining is 
noticed on the endothelial surface while vWF and alpha-smooth muscle actin stain 
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Figure 3. 7: TLR10 immunogold electron microscopy in cattle lung 
TLR10 staining (Figure 7A) (arrows) observed in a pulmonary intravascular macrophage 
(PIM), alveolar endothelium (EP) and endothelium (E). Figure 7B shows TLR10 staining 
(arrows) nucleus (N) and cytoplasm (C). The labeling is also observed on the plasma 
membrane (short arrows) in an alveolar macrophage in cattle lung. Figure 7C depicts 
TLR10 shows labeling (arrows) on luminal surface and cytoplasm of capillary 















Figure 3. 8: TLR10 protein expression in bovine neutrophils 
Control neutrophils (Figure 8A) show TLR10 staining (figure 8A). Neutrophils treated 








3.5 Discussion  
We report the first data on the expression of TLR10 in normal and inflamed lungs 
of cattle, pig, rat and chicken, and normal lungs of dog. In addition, we also show TLR10 
expression in control and LPS-treated isolated bovine neutrophils. The work contributes 
standardization of a commercially available TLR10 antibody for use in multiple 
veterinary species. In addition to the use of antibody to detect TLR10 in lungs of various 
species reported in this paper, the antibody also reacted with TLR10 in liver of rats and 
skeletal muscle of calves (data not shown). While immuno-histochemistry and western 
blots showed changes in TLR10 expression in control and inflamed lungs, the immuno-
electron microscopy provided data on subcellular localization of TLR10. Although the 
identity of a ligand for TLR10 is still elusive, the constitutive and altered expression of 
TLR10 in lungs may suggest its potential role in lung immunity.  
Bacterial and viral infections, and associated economic losses are the major 
concerns in animal industry (Aschenbroich et al., 2013; Pomorska-Mol et al., 2013). 
Since TLRs have central roles in detection and initiation of inflammation (Bafica et al., 
2005; Beutler, 2009), it is important to locate the tissue-cell specific expression of these 
receptors and any alterations in their expression in infected host. While many expression 
data are available for TLRs such as TLR4, TLR2 and TLR9, relatively little data have 
been published on TLR10 so far. Furthermore, most of the TLR10 expression data have 
been obtained in cultured cells or through the use of recombinant expression proteins 
(Guan et al., 2010; Kim et al., 2010; Selvarajoo et al., 2010). The challenge is further 
compounded in veterinary medical species where specific immunological reagents may 
not be available. Therefore, we characterized the commercially available anti-human 
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TLR10 antibody (Abcam; ab53631) to detect the 95-kDa-protein band in western 
blotting, corresponding to TLR10 protein. The peptide alignment of TLR10 protein from 
the multiple species showed the amino acid sequence similarity of 70%-90% with that of 
the peptide used to raise the antibody. We used this antibody for evaluating TLR10 
expression with light and electron microscopic immunocytochemistry and western blots. 
The western blots demonstrated TLR10 in lungs from all the species examined in 
this study. Furthermore, chicken lungs infected with E. coli and FAdV had increased 
expression of TLR10. The in situ localization of TLR10 was in the sub-epithelial areas in 
the airways, sub-endothelial areas of blood vessels, and the alveolar septa of the lungs. It 
appeared that TLR10 was mainly in the smooth muscles with little expression in the 
epithelial and endothelial cells.  This was confirmed with staining of serial sections of 
lungs of chicken.  It is interesting to note that while the light microscopic 
immunochemistry showed some basal TLR10 expression in lung septa, the fine 
localization with electron microscopic immunochemistry clearly defined the apical and 
cytoplasmic location of TLR10 in the septal cells. The presence of innate immune 
receptors in vascular endothelium provides an opportunity for the detection of blood-
borne pathogens and their products (Andonegui et al., 2003). TLRs present in the 
endothelium activate the immune system upon an encounter with specific antigen (Sabroe 
et al., 2008). Bacteria such as M. haemolytica enter host body primarily through airborne 
route than directly in to the blood (Confer, 1993; Ewers et al., 2004). This leads to a 
critical role for the immune receptors in lung in activation of innate immune system to 
produce antibacterial or antiviral agents to clear the infection. The implications of 
reduced expression and roles of TLR10 in lungs of M. haemolytica infected cattle needs 
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to be confirmed and analyzed through further experiments. It is possible that the bacteria 
may directly suppress TLR10 in lung to gain advantage and to establish infection. The 
expression of TLR10 in epithelial and endothelial surfaces of the lung may be important 
in lung pathophysiology; however, the identification of TLR10 ligand is urgently needed 
to understand the physiological importance of epithelial and endothelial TLR10 in the 
lung.  
  Macrophages are major regulators of immune responses in the lung. Alveolar 
macrophages present in the alveoli detect and remove inhaled bacteria and dust particles. 
PIMs are present in species such as cattle, sheep, goat, pigs, and horse and phagocytose 
blood-borne particles (Winkler, 1988; Chitko-McKown et al., 1991; Singh, 2004; 
Schneberger et al., 2012). Our data show TLR10 in both alveolar and intravascular 
macrophages in lungs of cattle and pig. Interestingly, electron microscopic data showed 
TLR10 in the nuclei of macrophages. Previously, we have demonstrated similar 
expression of TLR4 and TLR9 in lung macrophages of cattle and horses (Singh Suri et 
al., 2006; Schneberger et al., 2009). These TLR10 data make it clear that alveolar 
macrophages and PIMs have the TLR machinery that may allow them to respond to a 
variety of microbial molecules.  
Macrophages orchestrate immune responses through production of inflammatory 
molecules that recruit neutrophils. Neutrophils as first responders migrate towards the site 
of inflammation using chemoattractants and adhesion molecules, where they inactivate or 
destroy microbial products by producing proteolytic enzymes, antimicrobial proteins, and 
reactive oxygen species (Janeway and Medzhitov, 2002; Brinkmann et al., 2004). 
Because of the importance of neutrophils in acute inflammation, we examined TLR10 
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expression in them. Our data show that neutrophils themselves express TLR10, and in 
vitro activation with LPS changed the localization of TLR10 in neutrophils. Therefore, 
neutrophil TLR10 may also have the capability to detect yet to be identified TLR10 
ligand. 
Taken together these are the first data on the expression of TLR10 in normal and 
inflamed lungs of multiple veterinary species as well as bovine neutrophils in vitro. Once 
the identity of the ligand for TLR10 is revealed, these data will be foundational to 
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Toll-like receptors are innate immune receptors that play critical role in pathogen 
associated molecular pattern recognition. TLR10 is recently identified and its signaling 
pathway is still unclear. To study the expression pattern of TLR10 in primary immune 
cells, we examined TLR10 protein expression in normal and E. coli lipopolysaccharide 
(LPS) activated human neutrophils. Human neutrophils challenged with LPS showed a 
decreased TLR10 expression at 90min. Flow cytometry confirmed the reduced surface 
expression of TLR10 in 90min during LPS treatment.  Confocal microscopy showed 
cytosolic and nuclear distribution of TLR10 in normal and activated neutrophils. TLR10 
in LPS-activated neutrophils colocalized with flotallin-1, a lipid raft marker, and EEA-1, 
an early endosomal marker, to suggest its endocytosis. Colocalization analysis with 
TLR4 showed increased colocalization during 60min and a gradual decrease during the 
time. Decreased cytoplasmic localization of TLR10 was observed in TLR4 neutralized 
neutrophils when stimulated with LPS. Reactive Oxygen Species (ROS) depletion and 
neutralization of p65 in LPS-treated neutrophils resulted in decreased TLR10 expression. 
Live cell imaging of LPS-activated neutrophils showed TLR10 translocation in the 
leading edge and the role of TLR10 in chemotaxis was verified by the inability of TLR10 
knockdown neutrophils to move towards fMLP. However, TLR10 knockdown did not 
change the expression of key proteins of actin nucleation process, ARP-3 and Diap1. 








4.2 Introduction  
 
Toll-like Receptors (TLRs) are the innate immune receptors and their name 
comes from Toll receptor, which was identified for its roles in embryonic development in 
Drosophila (Hashimoto et al., 1988). TLRs recognize ligands derived from various 
microorganisms including bacteria, viruses, protozoa, and fungi (Alexopoulou et al., 
2001; Hayashi et al., 2001; Miettinen et al., 2001; Takeuchi and Akira, 2002; Lund et al., 
2003; Diebold et al., 2004; Heil et al., 2004; Latz et al., 2004; Takeda and Akira, 2004; 
Akira et al., 2006). So far, ten TLRs (1-10) have been reported in humans and 13 TLRs 
(1-9 and 11-13) in mouse. TLR10 is recently identified and is non-functional in mice due 
to retroviral insertions (Selvarajoo et al., 2010). Co-immunoprecipitation studies show 
that activated TLR10 forms homodimers, and makes heterodimers with TLR1/2 via extra 
cellular domains (Hasan et al., 2005). The structural studies of the cytoplasmic domains 
of TLR10 revealed MyD88 as the probable adaptor molecule (Nyman et al., 2008). 
Currently, the information about TLR10 signaling pathway, ligand identity, and function 
is scarce. Hence, it remains as an “orphan receptor” of the innate immune system.  
           TLR10 protein is expressed in organs such as lymph nodes, spleen, thymus, lungs, 
and immune cells such as macrophages and neutrophils (Chuang and Ulevitch, 2001). We 
have found that TLR10 is widely expressed in lungs of species such as pig, dog, cattle, 
and chicken and that its expression is altered in inflamed lungs (Balachandran et al., 
2015). The expression of TLR10 mRNA is found in early B cell development and the 
translation commitment mainly observed during B cell differentiation (Bourke et al., 




bowel disease characterized by mucosal dysfunction (Abad et al., 2011). TLR10 is 
identified as the key receptor in the innate immune response against L. monocytogenes 
through upregulation of chemokines CCL-20, CCL-1 and IL-8 through the nuclear 
translocation of NF-κB (Regan et al., 2013). Kim and colleagues showed the TLR10 
activation in THP-1 cell line under hypoxic conditions and proposed intracellular reactive 
oxygen species (ROS) and NF-κB activation as downstream effects of the activation 
(Kim et al., 2010). But recently, Oosting and colleagues reported that the TLR10 is an 
anti-inflammatory receptor because its neutralization in peripheral blood mononuclear 
cells increased production of proinflammatory cytokines such as IL-1β (Oosting et al., 
2014). Polymorphisms of TLR1- TLR6- TLR10 super family have been reported in 
diseases such as sarcoidosis and prostate cancer (Chen et al., 2007; Veltkamp et al., 
2012). Taken together, although the few available data implicate TLR10 in inflammatory 
response, the regulation of TLR10 expression and immune functions remains poorly 
understood.  
Neutrophils are central to the genesis of acute inflammation generated in response 
to bacteria or their products such as LPS (Standish and Weiser, 2009; Kumar and 
Sharma, 2010). LPS activates neutrophils upon binding to TLR4 expressed on their 
surface. Activated neutrophils migrate into sites of inflammation, produce anti-microbial 
products, undergo NETosis and kill bacteria (Branzk and Papayannopoulos, 2013). The 
anti-microbial products such as ROS produced by activated neutrophils also cause 
significant damage to the tissues, which is credited with morbidity and mortality (Lee et 
al., 2003). Neutrophils must extravasate from blood vessels to reach extravascular site of 




complex series of cellular and molecular events regulated by adhesive proteins, chemo-
attractants, and cytoskeletal reorganization. Kubes and colleagues have previously 
demonstrated the role of TLR4 in neutrophil chemotaxis in the lung (Andonegui et al., 
2003). However, there are no data on the regulation of TLR10 expression and its role in 
neutrophil chemotaxis.  
           To gain an understanding of the regulation of TLR10 expression and to address the 
issue of its role in neutrophil chemotaxis, we performed a series of in vitro studies. The 
data show that TLR10 is expressed in human neutrophils and LPS treatment altered 
TLR10 expression in human neutrophils. TLR10 gene knockdown induced chemotactic 
arrest in HL-60 derived neutrophils but it did not affect the expression of actin nucleation 
key proteins.   
 
4.3 Materials and Methods 
4.3.1 Reagents  
 
E. coli lipopolysaccharide (L6529) was obtained from Sigma Chemicals (St. 
Louis, USA). Anti-TLR10 polyclonal, anti-beta actin, anti-EEA1, anti-mouse IgG- FITC 
and anti-mouse IgG1-FITC were from Abcam (Cambridge, MA, USA), and anti-flotillin-
1 from Santa Cruz Biotechnology (California, USA). TLR4 neutralizing antibody and 
anti-Gr1 antibody commercially purchased from R&D systems (Minneapolis, USA). 
Peroxidase Substrate kit from Vector Laboratory Inc., (Burlingame, USA) and protein 
assay kit obtained Bio-Rad (Mississauga, Canada). RPMI-1640 purchased from ATCC 
(Manassas, USA), Reactive oxygen species detection kit was obtained from Invitrogen 





4.3.2 Ethical approval for human research 
 
Study on human neutrophils from healthy volunteers, was approved by Research 
Ethics Board of University of Saskatchewan, Saskatoon Canada. Licensed and trained 
personnel collected blood and got consent from all the volunteers.  
 
4.3.3 Isolation of neutrophils from human blood and stimulation 
 
Blood was collected intravenously from healthy volunteers and carefully added to 
the density gradient of Histopaque- 1119, 1083 and 1077 as described previously (Oh et 
al., 2008). Following centrifugation at 700g for 20min at room temperature, the layer 
between Histopaque 1119 and 1083 was aspirated and red blood cells were removed 
through hypotonic lysis. The cell pellet was suspended in RPMI 1640 with 10% FBS and 
viability checked by using tryphan blue. Cells were stimulated with bacterial LPS 
(1µg/ml) and harvested at 60min, 90min and 120min time interval.  
 
4.3.4 Flow Cytometry for TLR10 surface expression in neutrophils  
 
FACSCalibur flow cytometer (BD Biosciences, Mississauga, Canada) was used to 
perform the flow cytometry assays.  LPS treated cells were treated with Fc receptor 
blocker in order to reduce the background staining followed by the incubation with 
mouse antihuman TLR10 monoclonal antibody (0.35µg/ test; ab113446, Abcam) for 30 
min at 4°C. PE conjugated Gr-1 (0.30µg/ test; 108407, Biolegend) used as marker for 




anti-mouse IgG1as isotype control. FITC labeled anti-mouse IgG antibody used against 
TLR10.  
 
4.3.5 Confocal microscopy for TLR10, EEA1, Flotilin-1, TLR4, ROS and actin 
 
Confocal microscopy was performed using Leica TCS SP5 (Leica Microsystems, 
Germany) with 63X/1.2 oil immersion objective for image acquisition. Isolated 
neutrophils were incubated at 37°C and 5% CO2 in RPMI-1640 supplemented with 10% 
FBS and stimulated with E. coli LPS for 60min, 90min and 120min. Resting cells without 
LPS challenge in the same conditions were used as control for the experiment. Cells were 
fixed in 4% paraformaldehyde and permeabilized using 0.01% Triton X-100. Blocking 
with 5% BSA followed by primary antibodies against TLR10 (1:250), early endosomal 
marker, EEA1 (1:200), Flotilin-1 (1:150), Alexa 488- phallodin (165nM) according to the 
experiment and incubated 1hr at room temperature (Daniel and Kai, 2010). Fluorescent-
labeled secondary antibodies incubation was done for 30min at room temperature. DAPI 
was used to stain the nuclei. TLR4 neutralizing antibody (5µg/ml) was co-incubated with 
isolated neutrophils prior to LPS treatment and reactive oxygen species production was 
analyzed as marker for the receptor neutralization.  
To evaluate TLR10 translocation in activated live neutrophils, isolated human 
neutrophils were stained with FITC conjugated TLR10 antibody and washed gently to 
remove all unbounded dyes. The cells were resuspended in 1X sterile PBS and 150µl of 
the suspension was added to the center of glass bottom culture dish (MatTek Corporation, 




adding LPS (1µg/ml) to the cell suspension. Live cell activity was recorded for 120 min 
using time-lapse option.  
 
4.3.6 Western blotting for TLR10, Diap1 and ARP3  
 
After activation with LPS, isolated primary human neutrophils and HL-60 derived 
neutrophils (control and TLR10 knockdown) were lysed in RIPA buffer (Sigma, St. 
Louis, USA) with protease inhibitor cocktail. Immunoblots were prepared by anti-TLR10 
antibody (1:600, 1mg/ml; Abcam, Cambridge, USA), anti-Diap1 antibody (1:500, Cell 
Signaling Tech. USA), anti-ARP3 antibody (1:400, Cell Signaling Tech. USA). Anti-β-
actin (1:1000, Abcam, Cambridge, USA) was used as loading control. HRP-conjugated 
anti-goat or anti-rabbit (1:2000; DAKO, Burlington, Canada) was used as secondary 
antibody. Hybridization signals were detected in Amersham ECL western blotting 
detection reagents (GE Health care, Mississauga, Canada). Blots were digitally imaged 
and contrast adjustments were applied to all parts of the figure in an unbiased manner. 
Represented lanes indicate that only parts of the blot for better visualization. 
Quantification of bands from immunoblots was performed with densitometry in Adobe 
Photoshop CS6 (San Jose, USA).   
 
4.3.7 Quantitative RT-PCR for TLR10  
 
           Total RNA was isolated from LPS-treated human neutrophils using Qiagen 
RNeasy Mini kit followed by the treatment with RNase free DNase (Qiagen, Ontario, 
Canada) according to the manufacturer’s instructions. RNA was quantified by Nanodrop 




Ontario, Canada). Quantitative real time PCR was performed using Stratagene MX3005P 
PCR instrument and brilliant SYBR Green QPCR kit (Agilent Technologies, Santa Clara, 
USA) was used for the reaction. TLR10 (FP: 3’ ACTTTGCCCACCACAATCTC 5’ and 
RP: 3’ CCCAGAAAAGCCCACATTTA 5’) and GAPDH (FP: 3’ 
GAGTCAACGGATTTGGTCGT 5’ and RP: 3’ TTGATTTTGGAGGGATCTCG 5’) 
primers were obtained from Invitrogen (Burlington, Canada). ROX was used as reference 
dye for the PCR reaction. Specificity of the reaction was measured with non-template and 
no-reverse transcriptase controls and analysis of melting curves. GAPDH was used for 
normalization of the expression.  
 
4.3.8 Immunoelectron microscopy for TLR10 expression in neutrophils 
 
 Immunoelectron microscopy was performed on the neutrophils fixed in 2% 
paraformaldehyde and 0.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2). 
Nonspecific binding was blocked by incubating with 1% BSA and 0.1% Tween 20 in 1X 
TBS (pH 7.9) for 30min. The cells were incubated with primary goat anti-human 
polyclonal antibody (1:30) for 1hr at 25°C. Tissue sections were washed with TBS and 
incubated in 15mn gold particle labeled secondary antibody for 1hr (Singh Suri et al., 
2006).   
 
4.3.9 Small interference RNA induced TLR10 gene silencing in HL-60 cell lines 
 
           HL-60 cell line was transfected with commercially available siRNA transfection 
reagent using liposomes (Santa Cruz Biotechnology, 10410 Dallas, USA) after obtaining 




for TLR10 (sc-40272; Santa Cruz Biotechnology) and missense oligonucleotide negative 
control (sc-36869; Santa Cruz Biotechnology) were incubated with transfection reagent 
for 45min to form transfection reagent-siRNA complex and added to the cells washed 
with transfection medium. HL-60 cells were incubated for 8hr in the transfection mixture 
and were recovered by washing with RPMI-1640. Transfected cells were incubated in 
complete RPMI-1640 medium for 48hr followed by their differentiation into neutrophil 
lineage through incubation in 1.3% DMSO for 5 days. Visual confirmation of 
differentiation was done by light microscopy.  
 
4.3.10 Statistical analysis  
 
         One-way ANOVA was used for the comparison between the groups and p values 
with 0.05 or less than 0.05 was considered significant. Results are represented as Mean + 
SEM of three replicates. Graph Pad Software (Avenida de la Playa, CA, USA) was used 
for all the analysis. 
 
4.4 Results 
4.4.1 Bacterial lipopolysaccharide alters the expression of TLR10 in human 
neutrophils 
First, we examined the effect of bacterial LPS on the expression of TLR10 in 
human neutrophils. As shown in Figure 4.1A, the LPS treatment altered the localization 
of TLR10 in human neutrophils. The control neutrophils expressed TLR10 on their 
plasma membrane whereas at 60min of LPS treatment, TLR10 was observed mainly in 




90min of LPS treatment and reappeared on the membrane at 120min. We also noticed 
TLR10 expression in the nuclei of control as well as LPS-treated neutrophils. Flow 
cytometry confirmed reduction and reappearance of surface expression of TLR10 at 
90min and 120min of LPS-treatment, respectively (Fig. 4.1B). We examined TLR10 
expression in LPS-stimulated human neutrophils using western blotting (Fig. 4.1C, D). 
The TLR10 expression was reduced at 90min compared to control, 60min and 120min of 
the LPS treatment (p<0.05). Lastly, we determined transcriptional level expression of 
TLR10 with quantitative RT-PCR and found an increase in mRNA level of TLR10 at 
60min of LPS-treatment compared to the controls (Appendix: Supplementary 
information. 4.1).  
 
4.4.2 LPS induces the lipid raft mediated endocytosis of TLR10 
 
We analyzed whether increase in cytoplasmic localization of TLR10 is through 
endocytosis. Quantitative colocalization of TLR10 with early endosomal antigen-1 (EEA-
1), an endosomal marker protein, was performed at 60min, 90min, and 120min of the 
LPS treatment.  Figure 4.2A shows TLR10-EEA1 colocalization in the cytoplasm of 
neutrophils at 60min and 90min treatment. At 120min of the LPS treatment, we observed 
colocalization signal on the plasma membrane compared to 60min and 90min of the 
treatment. The relocalization of TLR10 on plasma membrane at 120min was consistent 
with the observation in Figure 4.1A. Quantification of colocalization in terms of 
Pearson’s Coefficient (p<0.05) is shown in Fig. 4.2B. The incubation of cells at 4oC 
impaired increase in cytoplasmic localization of TLR10 to suggest receptor-mediated 




 To determine the role of lipid rafts in TLR10 endocytosis, we examined the 
colocalization of TLR10 with flotillin-1, a resident lipid raft protein. The data show 
significant increase in colocalization of TLR10 with flotillin-1 after the neutrophil 
activation by LPS. We used methyl-beta-cyclodextrin (β-MCD; 1mM for 30min) to 
disrupt the lipid raft and this led to the inhibition of TLR10 endocytosis (Appendix: 
Supplementary information.4. 3). Figure 4.2C shows plasma membrane staining of 
flotillin-1 in control neutrophils. Fluorescent intensity of colocalization signal of TLR10 
and flotillin-1 was increased at LPS 60min compared to the control neutrophils. Flotillin-
1 staining on plasma membrane returned to control values at 120min of LPS treatment. 
Figure 4.2D represents the quantification of colocalization in terms of Pearson’s 
Coefficient (p<0.05).  
 The ultra-cellular localization of TLR10 was confirmed with immunoelectron 
microscopy of control neutrophils (Fig. 4.3A). Neutrophils treated with LPS for 60min 
showed TLR10 aggregation on neutrophil pseudopods (Figure 4.3B). TLR10 was 
detected on plasma membrane, cytoplasm and nucleus of neutrophils at 120min of LPS 
treatment (Fig. 4.3C).  
 
4.4.3 TLR10 colocalizes with TLR4 in LPS activated human neutrophils 
 
Since bacterial lipopolysaccharide activates TLR4, we decided to examine the 
changes in TLR4 along with TLR10 expression on LPS challenge (Fig. 4.4A). At 60min 
of the LPS treatment, cytoplasmic colocalization of TLR10 with TLR4 was significantly 
increased compared to control neutrophils as well as those at 90min and 120min of LPS 





4.4.4 Bacterial lipopolysaccharide-induced TLR4 activation regulates TLR10 
expression and localization dynamics through reactive oxygen species  
Bacterial LPS activates TLR4 that leads to the nuclear translocation of NF-κB, 
and production of reactive oxygen species (ROS) and proinflammatory cytokines 
(Yamada et al., 2006). Therefore, we assessed the role of LPS-induced TLR4 activation 
in TLR10 expression. TLR4 signaling pathway was inhibited with a TLR4 neutralizing 
antibody (5µg/ml) and production of ROS was monitored as marker for TLR4 
neutralization. ROS production from TLR4-neutralized and LPS-treated neutrophils was 
significantly diminished when compared with LPS treated cells without neutralizing 
antibody (Fig. 4.5A). TLR10 expression was examined in untreated control cells, LPS-
treated cells, and the cells treated with LPS for 60min and TLR4 neutralizing antibody. 
TLR4 neutralization in LPS-treated neutrophils significantly reduced TLR10 expression 
compared to the controls (Fig. 4.5B-C).  
Since ROS production is characterized as one of the major effector events in LPS-
treated neutrophils, we assessed the role of ROS in TLR10 expression. It has been 
demonstrated that LPS can rapidly induce ROS production through NADPH oxidase 
activation and lead to endothelial necrosis (Simon and Fernández, 2009). We used 
Trifluorocarbonylcyanide Phenylhydrazone (FCCP) as an uncoupler of oxidative 
phosphorylation and electron transport chain to prevent ROS induction in LPS treated 
neutrophils. Neutrophils treated with FCCP (5µg/ml) prior to incubation with LPS for 
60min did not show an increase in TLR10 expression and cytoplasmic localization when 




analyzed the effect of nuclear translocation of p65 on TLR10 expression. Neutralization 
of p65 using an inhibitor peptide also reduced TLR10 expression (Fig. 4.6B). Taken 
together, these data show that ROS production and nuclear translocation of NF-κB after 
TLR4 activation by LPS regulates TLR10 expression. 
 
4.4.5 TLR10 knockdown inhibits neutrophil chemotaxis  
 
To examine the dynamic localization of TLR10 in live LPS-activated human 
neutrophils, we performed live single cell imaging. The data show FITC-labeled TLR10 
preferentially localized to the leading edge of the neutrophils (Fig. 4.7A, Supplementary 
information. 5- video.1).  Because human neutrophils are short-lived cells in culture, we 
used HL-60 cell line to assess the role of TLR10 in neutrophil chemotaxis. The effective 
knockdown of TLR10 in HL-60 cells (Fig. 4.7B-C) led to significant reduction in their 
chemotaxis towards fMLP (50nM) (Fig. 4.7D). To understand the underlying mechanism 
of regulation of chemotaxis by TLR10, we analyzed the changes in the expression of 
ARP3 and Diap1, which are key proteins involved in the process of actin nucleation. The 
Western blot data did not show differences in the expression of ARP3 and Diap1 (Fig. 
4.8). Confocal imaging on control and TLR10 knockdown neutrophils confirmed the 
inability of TLR10 knockdown neutrophils to form the pseudopodia against fMLP 
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Figure 4. 1: LPS mediated temporal expression changes of TLR10 
 
(A) Time dependent expression of TLR10 (in green) in human neutrophils (1 X 106). 
Nuclei stained in blue with DAPI. Neutrophils were treated with 1µg/ml LPS for 60, 90 
and 120min (n=3). Imaged the temporal expression changes and localization of TLR10 
expression during the treatment time in confocal microscopy. (B) Neutrophils stimulated 
with LPS (1µg/ml) for 60, 90 and 120min and stained with antibodies against TLR10 and 
isotype–matching antibody for flow cytometry analysis. FITC-TLR10 fluorescent 
spectrum shift was used to analyze TLR10 surface expression changes. (C) Immunoblots 
lysates of neutrophils (2 X 106). Cells were stimulated with LPS (1µg/ml) for 60min, 90 
min and 120min. Molecular weight is depicted on the left side of the blots. β-actin 




the down regulation of TLR10 expression in neutrophils treated with 90min and 
increased gene expression in LPS 120min (*p <0.05, compare with control; **p < 0.05, 
compare with LPS 60min). One representative experiment of three in the above 
































Figure 4. 2: Lipid raft mediated endocytosis of TLR10 
 
 (A, B) Human neutrophils (1 X 106) adhered to FBS coated coverslips were activated by 
LPS (1µg/ml). Colocalization of TLR10 (red) and early endosomal antigen, EEA1 
(green) are shown in merge panel. Treatment time points were 60min, 90min and 
120min. Lower panel shows the graphical representation of quantification of 
colocalization in terms of Pearson’s coefficient (*p<0.05), analyzed by Imaris 7.4 
(Bitplane Inc., USA) using ImarisColoc module. (C, D) Colocalization of TLR10 (green) 
and flotillin-1, lipid raft marker (red) in LPS (1µg/ml) treated human neutrophils (1 X 
106) adhered to FBS coated coverslips. Intact plasma membrane in control cells and 
membrane rearrangement during 60 – 120min was observed. Lower panel shows the 
graphical representation of quantification of degree of colocalization in terms of 
Pearson’s coefficient (*p<0.05), analyzed by Imaris 7.4 (Bitplane Inc., USA) using 
















Figure 4. 3: Ultra-localization of TLR10 in human neutrophils 
 (A-C) Immuno-gold electron microscopy for TLR10 in human neutrophils shows the 
presence of TLR10 in nucleus, cytoplasm as well as in the plasma membrane (Red 
arrows). Note the TLR10 localization in pseudopodia of E. coli LPS (1µg/ml) activated 
















Figure 4. 4: TLR10 colocalized with TLR4 on LPS challenge 
 
(A) Isolated human neutrophils (1 X 106) adhered on FBS coated coverslips were 
challenged with LPS (1µg/ml) for 60min, 90min and 120min and examined by confocal 
microscopy for the colocalization of TLR10 (in green) and TLR4 (in red). Merged 
channel indicate the overlapping signals from TLR10 and TLR4 along with nuclear stain 
DAPI. (B) Quantification of colocalization in terms of Pearson’s coefficient analyzed by 
Imaris 7.4 (Bitplane Inc, USA) using ImarisColoc module. (*p < 0.05, compared with the 
control and **p < 0.05, compared with LPS 60min and all data shown in terms of mean + 
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Figure 4. 5: TLR4 neutralization reduced TLR10 expression  
(A) TLR4 neutralizing antibody (5µg/ml) co-incubated with isolated human neutrophils 
(1 X 106) for 1hr to inhibit bacterial LPS induced TLR4 signaling pathway. Cells were 
treated with bacterial LPS (1µg/ml) for 60min after TLR4 neutralization. ROS generation 
(in green) was measured as the marker for TLR4 neutralization and observed low ROS 
production in cells treated with neutralizing antibody. DAPI used to visualize the nuclei. 
(B) Isolated human neutrophils (1 X 106) treated for TLR4 neutralization and activated 




confocal microscopy and merged image in the third column indicates the expression and 
cytoplasmic localization of TLR10 in control, LPS 60min treated as well as neutralizing 
antibody pretreated cells challenged with bacterial LPS for 60min. (C) Quantification of 
fluorescence in terms of corrected total cell fluorescence analyzed by Image J v1.47 
(nih.gov, USA) using grey scale intensity analysis. (*p < 0.05, compared with the and all 
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Figure 4. 6: ROS and NF-κB inhibition reduced TLR10 expression 
 
 (A) Human neutrophils (1 X 106) pretreated with Trifluorocarbonylcyanide 
Phenylhydrazone (Zablockaite et al., 2007), 5µg/ml, for 1hr at 37°C to deplete ROS 
production. Cells were measured for ROS generation (data not shown) to confirm the 
inhibitory activity of FCCP pretreatment. FCCP pretreated cells were challenged with 
bacterial LPS (1µg/ml) for 60min and imaged for TLR10 (in red) using confocal 
microscopy. Merged image shows TLR10 localization with nuclear stain, DAPI (B) 
Isolated human neutrophils (1 X 106) treated for NF-κB inhibitor and treated using 
bacterial LPS, conditions as above. TLR10 (in green) was imaged using confocal 
microscopy and merged image in the third column indicates the expression and 
cytoplasmic localization of TLR10 in control, LPS 60min treated as well as NF-κB 
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Figure 4. 7: Role of TLR10 in neutrophil chemotaxis 
 (A) Frames captured from live single cell imaging of human neutrophils. Neutrophils 
were labeled with anti-TLR10 antibody tagged with FITC (protocol as explained above) 
and imaged under Leica SP5 confocal microscope with heated stage (temperature 
maintained constantly at 37°C). Neutrophils were activated with concentration gradient 
of LPS (1µg/ml) attained by pipette tip diffusion and imaged for 100min. (B) HL-60 cell 
line was transfected with 80nM of TLR10 siRNA (sc-40272; Santa Cruz Biotechnology) 
using liposome-mediated transfection (Santa Cruz Biotechnology, 10410 Dallas, USA) 
after obtaining 80% confluence in culture. HL-60 differentiation in to neutrophils was 
achieved by the incubation with 1.3% DMSO for 5 days. Isolated mRNA used for 




Immunoblots lysates of HL60 differentiated neutrophils (2 X 106). Cells were treated 
with 20nM, 40nM and 80nM of TLR10 siRNA and total protein isolate was hybridized 
against anti-TLR10 antibody. Molecular weight is depicted on the left side of the blots. 
(D) Chemotaxis experiment was performed using Boyden chamber with control, TLR10 
knockdown, LPS treated (60 min; 1µg/ml) and TLR10 knockdown+ LPS treated (60min; 
1µg/ml). Migrated cells from at least 5 different fields were counted and tallied. One 














































































































Figure 4. 8: TLR10 does not affect actin nucleation 
 (A) Immunoblots lysates of HL-60 derived neutrophils (2 X 106). TLR10 gene 
knockdown was performed as above and cells were stimulated with LPS (1µg/ml) for 
60min. Actin nucleation proteins- ARP3 (1:500) and Diap1 (1:400) were detected in the 




left side of the blots. β-actin showed in the lower panel referred as loading control. (B & 
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Figure 4. 9: TLR10 knockdown decreased formation of pseudopodia 
Control (A) and TLR10 silenced (B) HL-60 derived neutrophils (1 X 106) were 
challenged with 1µM fMLP for 1min. F-actin (165nM) stained in green and nuclei (blue) 
stained with DAPI. Arrows (red) indicate pseudopodia formation. (C&D) Control and 
TLR10 knockdown HL-60 derived neutrophils (1 X 106) were challenged with 1µM 
fMLP for 1min. TLR10 stained in green and nuclei in blue stained with DAPI (E) 
Difference between the cells with pseudopodia in control and TLR10 knockdown groups. 
HL-60 derived neutrophils (1 X 106) were challenged with 1µM fMLP for 1min, imaged 












Although TLR10 was characterized in early 2000 (Chuang and Ulevitch, 2001), 
there are very little data on signaling pathway,  ligand, and role of TLR10 in innate 
immunity. Hence, it is known as an “orphan receptor” of innate immunity. Functional 
TLR10 is not present in mice due to retroviral insertions in the TLR10 encoding gene 
thus precluding the use of mouse models to study the biology of TLR10. Neutrophils are 
the main effectors of innate immune system and first responders against a bacterial 
infection (Amulic et al., 2012). Hence, in this study, we provide novel data on the 
expression kinetics, localization dynamics in human neutrophils, and its role in TLR10 in 
chemotaxis.  
First, we examined TLR10 expression and its regulation in neutrophils. Because 
the identity of TLR10 ligand is still not known, we used LPS to activate neutrophils via 
TLR4 pathway to understand the effect of cell activation on TLR10 expression. The 
TLR10 expression was reduced at 90min of LPS treatment and recovered to control 
values by 120min of the treatment. The new TLR10 gene transcription observed at 60min 
probably restored the TLR10 protein expression at 120min. Even more interesting is the 
rapid changes in plasma membrane expression of TLR10 through its endocytosis by 
activated neutrophils. Neutrophil activation led to changes in spatial and temporal 
expression of TLR10. Similar to TLR4 (Martha Triantafilou and Triantafilou, 2002), 
TLR10 endocytosis is also dependent on integrity of lipid rafts because the endocytosis 
was inhibited following disruption of lipid rafts. Taken together, the data show highly 




Second, we analyzed the mechanisms of regulation of TLR10 expression in 
activated neutrophils. Neutrophils upon stimulation with LPS produce ROS and 
translocate NF-κB into their nuclei (Neubauer et al., 2013). Earlier reports showed that 
ROS production is crucial in TLR4 dependent nuclear translocation of NF-κB 
(Asehnoune et al., 2004). ROS also contribute to LPS-TLR4 pathway induced 
upregulation of TLR2 in lung endothelial cells (Fan et al., 2003; Xiang et al., 2010). Kim 
and colleagues reported the increase in TLR10 mRNA expression with an increase in 
intracellular ROS (Kim et al., 2010). The data show that LPS-induced ROS production 
upregulates TLR10 expression in activated neutrophils because ROS depletion with 
FCCP inhibited increase in TLR10 expression. Our data also show that LPS alters TLR10 
expression through TLR4 pathway as the effects were neutralized with a TLR4 
neutralizing antibody, and thus, showing potential cross talk between TLR4 and TLR10. 
Lastly, the inhibition of nuclear translocation of NF-κB in neutrophils blocked LPS-
induced changes in TLR10 expression to underscore the role of new gene transcription in 
regulation of TLR10 expression. Taken together, these data show that TLR4 pathway 
mediated production of ROS and nuclear translocation of NF-κB regulate the expression 
of TLR10 in activated neutrophils.   
There are very limited data on the role of TLR10 in neutrophil biology. Our data 
show a novel role for TLR10 in neutrophil chemotaxis, one of the primal functions of 
neutrophils. Even though TLRs are involved in PAMPs detection and regulation of 
proinflammatory cytokine secretion, which promotes leukocyte recruitment to the site of 
injury, many reports argue for the role of activated TLR in inhibiting leukocyte 




2012a). However, there are contradictory data stating the modulatory effects of TLR 
activation on neutrophil chemotaxis. Fan and colleagues reported increased chemotaxis 
towards MIP-2 in LPS-challenged neutrophils. LPS induced TLR4 activation 
downregulated G-protein-coupled receptor kinases (GRK) 2 and 5, which in turn 
desensitized chemokine receptors on neutrophils, resulted in enhancing the chemotactic 
response (Fan and Malik, 2003b; Hayashi et al., 2003; Aomatsu et al., 2008a). 
Meanwhile, Filho and co-workers showed TLR2 signaling induced with LTA 
upregulated GRK2 expression and inhibited neutrophil chemotaxis (Alves-Filho et al., 
2009). My video-microscopy of live neutrophils and immuno-electron microscopy of 
fixed and embedded neutrophils showed aggregation of TLR10 on the leading edge of 
activated neutrophils. The TLR10 knockdown results in reduced chemotaxis of 
neutrophils towards fMLP along with a reduction in the numbers of plasma membrane 
pseudopods. Previous studies have shown that TLRs regulate actin polymerization, 
phagocytosis and chemotaxis by modulating MAPK, Cdc42, and Rac1 pathways (Doyle 
et al., 2004; Kong and Ge, 2008; Alves-Filho et al., 2009). We further attempted to 
address the role TLR10 in ARP3 and Diap1 proteins expression, which involve in actin 
nucleation, one of the steps in pseudopod formation. However, the western blot data 
showed no differences in the expression of these proteins in normal neutrophils or those 
subjected to TLR10 knockdown. While there is need for further experiment to understand 
the mechanisms that regulate reduction in membrane pseudopods following in TLR10 





Genetic polymorphisms of TLR10 have been reported in a number of 
inflammatory diseases such as asthma, Crohn’s disease, prostate cancer etc. (Lazarus et 
al., 2004; Chen et al., 2007) indicating its functional role in immune system and the 
molecular mechanisms need to be explored. However, our data are the first to show 
detailed expression, dynamics, ultrastructural localization, and functional roles of TLR10 
in bacterial LPS induced innate immune response. It is plausible that TLR10 contributes a 
key regulatory role in innate immunity and this basic data opens an intriguing area for 
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Toll-like Receptors (TLRs), known as “Gate Keepers” of innate immunity, are 
evolutionarily conserved receptors to recognize pathogen-associated molecular patterns. 
TLRs play a critical role in innate immunity and in early response against invading 
pathogens. Even though, TLRs have been widely studied, very little is known about the 
expression and function of TLR10. Since TLR10 is a pseudogene in mice, there are no 
successful rodent animal models to study the function of TLR10 through genetic 
manipulations. Till date, no data are available on tissue and cell specific expression of 
TLR10 in normal and inflamed human lungs as well as in primary immune cells such as 
macrophages. S. pneumoniae are Gram-positive, alpha-hemolytic and major causative 
agents of pneumonia, ear infections, sinus infections, meningitis, and bacteremia. We 
examined the role of TLR10 in innate immune response to S. pneumoniae infection in 
U937 cell line derived human macrophages. We found a significant increase in TLR10 
mRNA expression in macrophages challenged with S. pneumoniae (107 cfu for 6hr). 
TLR10 knockdown resulted in significant reduction in expression of IL-1β, IL-8, IL-17 
and TNF-α but didn't affect IL-10 expression. TLR10 knockdown also reduced nuclear 
translocation of NF-κB during macrophages challenged with S. pneumoniae. However, 
TLR10 knockdown had no effect on the phagocytosis of the bacteria by the macrophages. 
TLR10 expression in vascular endothelium in normal and inflamed human lungs was 
confirmed by immunohistochemistry. Taken together, our data show that TLR10 is 
expressed in human lung vasculature and macrophages, and regulates expression of 








Streptococcus pneumoniae is a gram positive diplococcus human pathogen 
responsible for approximately 1.2 million infant deaths per year around the globe 
(O’Brien et al., 2009; PHAC, 2011). S. pneumoniae colonizes the upper respiratory tract 
and causes lethal meningitis, pneumonia, and sepsis (Chiavolini et al., 2008; Bogaert et 
al., 2009). Pneumolysin (PLY), an exotoxin with cytotoxic activity, is the important 
virulence factor of S. pneumoniae. PLY of most pneumococcal strains is cytotoxic to 
mammalian cells by forming large pores into membranes (Sutherland and Martin, 2007).  
The first recognition of invading pathogens such as S. pneumoniae by the host is 
mediated by pattern recognition receptors (PRRs) of the immune system. So far 10 TLRs 
have been identified in humans namely TLR1 to 10 (Takeda et al., 2003). TLRs are 
highly conserved PRRs, which detect specific pathogen associated molecular patterns 
(PAMPs), initiate a cascade of reactions and lead to the activation of proinflammatory 
cytokine production to remove the invading pathogen. Upon binding to their specific 
ligands, TLRs trigger the innate inflammatory response through the activation of series of 
adaptor molecules (Beutler, 2009). Previous data suggest TLR 2, 4 and 9 play important 
roles in modulating bacterial susceptibility, higher bacterial loads, and heightened upper 
respiratory tract cell apoptosis during S. pneumoniae infection (Koppe et al., 2012). 
Increasing evidence indicates that activation of innate immune system is an essential 
criterion for the induction of adaptive immunity. Based on the protein sequences and 




subfamilies: TLR1, 2 and 6 subfamily recognizes lipids, TLR7, 8 and 9 subfamily 
recognize nucleic acids (Akira et al., 2006).  
TLR10 is recently identified TLR family protein and is non-functional in mice 
due to exonal retroviral insertions (Chuang and Ulevitch, 2001).  TLR10 is functional in 
humans and is expressed by immune cells like dendritic cells, macrophages, and B cells. 
TLR10 is present in the lungs of many species including pig, dog, cattle, mice and 
chicken (Balachandran et al., 2015). Sequence analysis confirmed that TLR10 aligns in 
the same locus with TLR1 and 6. The ligand of TLR10 is still unknown. TLR10 forms 
homodimers with each other as well as heterodimers with TLR1 and TLR2 (Hasan et al., 
2005). TLR1-TL6-TLR10 gene cluster polymorphism can increase disease susceptibility 
for prostate cancer (Chen et al., 2007). TLR10 polymorphisms were observed in patients 
with clinical symptoms of Crohn’s disease, papillary thyroid carcinoma, urothelial 
bladder cancer, Turkish rheumatoid arthritis, and asthma (Lazarus et al., 2004; Etem et 
al., 2011; Guirado et al., 2012; Morgan et al., 2012; Kim et al., 2013). While lack of a 
recognized ligand for TLR10 hinders many functional studies, it is known that hypoxia 
upregulates TLR10 mRNA in human monocytic cell line, THP-1, through activation of 
reactive oxygen species (ROS), NF-κB, and AP-1 pathways. Luciferase binding assays 
indicated a potential NF-κB binding site in TLR10 gene sequence (Halliwell et al., 1999; 
Kim et al., 2010). Viral infection in dendritic cells caused TLR10 upregulation and 
activation of interferon 1 signaling pathway (Hertzog et al., 2003). The data reported in 
this thesis (Chapter 4) also show the regulation of TLR10 expression in neutrophils via 
ROS and NF-κB pathways following ligation of TLR4 with LPS. Currently, there are no 




Although the interaction between innate immune receptors and bacterial 
pathogens has been extensively studied, little is known about the role of TLR10 in innate 
immune reaction against gram-positive bacteria. Therefore, first we examined the 
expression of TLR10 in the human lung. Following that we studied the role of TLR10 in 
responses to S. pneumoniae infection by U937 derived macrophage cells. Our data 
suggests that TLR10 is expressed in human lungs including epithelial cells and 
macrophages, the expression of TLR10 is upregulated during S. pneumoniae infection 
and TLR10 regulates the production of IL-1β, IL-8, IL-17 and TNF-α.  
 
5.3 Materials and methods 
5.3.1 Cell culture 
 
U937 is a human histiocytic lymphoma cell line purchased from ATCC (CRL-
1593.2), maintained in RPMI-1640 media (ATCC) with 10% FBS (Life Technologies), 
and supplemented with 10µg/ml penicillin and streptomycin (Sigma Aldrich). The cells 
were incubated at 37°C with 5% CO2. Differentiation of U937 cells into macrophage 
lineage was achieved in 48hr using 20nM Phorbol-12-Myristate-13-Acetate (PMA; 
Sigma Aldrich). Invasive live S. pneumoniae (See below) used to challenge the cells.  
 
 
5.3.2 Bacterial culture and infection 
 
S. pneumoniae (Klein Chester ATCC 6303) strain with type 3 antigenic properties 
was commercially purchased from ATCC (Manassas, USA). Bacteria were cultured in 




24hr supplemented with 5% CO2. Bacterial dilution and count were estimated using 
McFarland standard dilution comparison method. In brief, we compared 24hr grown S. 
pneumoniae culture to McFarland standard 5 (turbidity scale-5; OD equivalent- 0.65) and 
allowed the culture to reach the known OD of McFarland standard 5. We made serial 
dilutions (10-1- 10-7) of the bacterial culture (OD=0.65) and plated in Columbia blood 
agar and incubated over night to calculate the colony forming units corresponding to each 
dilution. For infecting the macrophages, desired dilution of S. pneumoniae culture in log 
phase was washed with PBS and added to U937 derived macrophage cells with antibiotic 
free media.  
 
5.3.3 Small interfering RNA transfection to knockdown TLR10 gene expression  
 
After attaining 80% confluence, U937 derived macrophages were transfected with 
TLR10 siRNA using commercially available liposomal transfection system  (Santa Cruz 
Biotechnology, 10410 Dallas, USA). In brief, 80nM of TLR10 siRNA (sc-40272; Santa 
Cruz Biotechnology) was incubated with transfection reagent for 45min to form 
transfection reagent-siRNA complex and added this mixture to the cells washed with 
transfection medium. Cells were incubated for 8hr in the transfection mixture followed 
by a wash with and incubation in RPMI-1640 medium for 48hr.  
 
5.3.4 Quantitative real time PCR 
 
Total RNA was isolated from the macrophage cell line incubated with S. 
pneumoniae using Qiagen RNeasy Mini kit followed by the treatment with RNase free 




quantified by Nanodrop method and cDNA was prepared using Quantitect Reverse 
Transcription Kit (Qiagen, Ontario, Canada). Quantitative real time PCR was performed 
to quantify transcriptional level expression of IL-1, IL-8, IL-17, TNF-α and IL-10 using 
Stratagene MX3005P PCR instrument and brilliant SYBR Green QPCR kit (Agilent 
Technologies, Santa Clara, USA) was used for the reaction. Primers were obtained from 
Invitrogen (Burlington, Canada) and sequences are listed as in Table. 1. ROX was used 
as reference dye for the PCR reaction. Specificity of the reaction was measured with non-
template and no-reverse transcriptase controls and analysis of melting curves. GAPDH 
was used for normalization of the expression. 
 
5.3.5 Confocal microscopy for TLR10 and NF-κB 
 
U937 derived macrophages were cultured in 37°C and 5% CO2 in RPMI-1640 
with 10% FBS. Live S. pneumoniae cells (107 cfu/well) were inoculated for 6hr and 
incubated as described above. Four percent paraformaldehyde was used as a fixative and 
cells were permeabilized with 0.01% TritonX 100. Nonspecific antigens were blocked by 
5% BSA.  Fcγ blocking was performed as previously described (Sedlmayr et al., 2001). 
TLR10 (1:250) and anti-NF-κB p65 (1:200) primary antibodies incubated for 1hr at room 
temperature.  Fluorescent-labeled secondary antibody incubation was done for 30 min at 
room temperature. Cells were mounted in medium containing DAPI and left overnight 
for proper conditioning of the slides for imaging. S. pneumoniae were labeled with 
Oregon green (Maximum excitation at 511nm, maximum emission at 530nm). Confocal 
microscopy was performed in Leica TCS SP5 system (Leica Microsystems, Germany) 





5.3.6 Immunohistochemistry for TLR10 in human lungs 
 
Immunohistochemistry was performed on sections obtained from paraffin 
embedded lung tissue samples from control (n=7) and asthmatic (n=6) humans. The 
sections were deparaffinized and rehydrated followed by incubation with 5% hydrogen 
peroxidase to neutralize endogenous peroxidase. The antigen retrieval step included 
treatment with pepsin (2mg/ml in 0.01N HCL). The sections were exposed to BSA (1% 
BSA in 1X PBS) to block non-specific binding of immunoglobulins. We used von 
Willebrand factor (vWF; 1: 750) as a positive control because it is constitutively 
expressed in vascular endothelium (Itaru et al., 2002) whereas staining without primary 
antibody and staining with isotype matching antibody were used as negative control. 
Lung sections were stained for TLR10 (1: 150). The color development was performed 
with Vector color developing agents after HRP conjugated secondary antibody incubation 
(1: 150, Dako Laboratories, Denmark).  
 
5.3.7 Statistical analysis 
 
Results were represented as mean + SEM and analyzed using Student t- test. A p 
value < 0.05 was considered as statistically significant. All analyses were performed in 









5.4.1 TLR10 is expressed in U937 derived human macrophages and its expression is 
upregulated by S. pneumoniae  
We investigated the effect of size of live S. pneumoniae inoculum (105, 106, 107 
and 108 cfu) and time (3hr, 6hr, 12hr and 24hr) of incubation on TLR10 expression on 
U937 derived human macrophages. TLR10 mRNA expression was significantly 
upregulated with 107 and 108 cfu live S. pneumoniae compared to control after 6hr of 
culture with the macrophage cell line (Fig. 1A). Highest levels of TLR10 mRNA 
expression were recorded in macrophages treated with 107 cfu S. pneumoniae for 6hr but 
significantly higher TLR10 mRNA was observed at 2, 6 and 12hrs of infection (Fig. 1B).  
TLR10 protein expression and localization after infection with live S. pneumoniae was 
also determined by confocal microscopy. TLR10 was expressed in the cytoplasm of 
control macrophages. However, 6hr of incubation with 107 cfu of S. pneumoniae induced 
more intense and diffuse TLR10 expression in the cytoplasm and the nucleus. Corrected 
total cell fluorescence showed higher fluorescence intensity of TLR10 staining in 
macrophages incubated with S. pneumoniae for 6hr compared to the control macrophages 








5.4.2 TLR10 regulates cytokine induction in response to S. pneumoniae infection  
 
We next investigated the effect of TLR10 on selected proinflammatory (IL-1β, 
IL-8, IL-17 and TNF-α) and anti-inflammatory (IL-10) cytokines after 6hr of S. 
pneumoniae challenge. The knockdown of the TLR10 protein expression in macrophages 
was achieved by using 80nM TLR10 siRNA (Fig. 2A) and confirmed with confocal 
microscopy (Fig. 2B). The knockdown of TLR10 in macrophages infected with S. 
pneumoniae significantly reduced the expression of IL-1β (61%), IL-8 (62.8%), IL-17 
(47%), and TNF-α (32%) mRNA compared with control macrophages (Fig. 3A-D). IL-10 
mRNA expression was not affected by TLR10 knockdown (Fig. 3E).  
 
5.4.3 TLR10 does not affect phagocytosis of S. pneumoniae  
 
In order to investigate whether TLR10 silencing influences the phagocytic activity 
of macrophages, which may have subsequently affected the production of inflammatory 
mediators, we incubated the control macrophages as well as those following TLR10 
knockdown with fluorescent-labeled live S. pneumoniae for 6hr. Cells were imaged under 
confocal microscopy and counted number of bacterial cell per macrophages. Analysis of 
phagocytic activity showed no significant difference between control and TLR10 
knockdown macrophages (Fig. 4A-B).  
 
5.4.4 TLR10 knockdown reduced nuclear translocation of NF-κB 
 
To investigate the mechanisms through which TLR10 regulates cytokine 




knockdown reduced the nuclear translocation of NF-κB in S. pneumoniae challenged 
macrophages compared to the control suggesting that NF-κB might be the effector 
molecule of TLR10 receptor activation (Fig. 5A). Western blots on the nuclear extracts 
from the above experiment showed reduced nuclear localization of NF-κB in 
macrophages (Fig. 5B) in macrophage cells that had their TLR10 knocked down 
compared to the controls.  
 
5.4.5 Inflammation increased the expression of TLR10 in human lung 
 
When asthma patients acquire viral infections, which, in turn, trigger the 
asthmatic response, they may develop subsequent bacterial infections, mainly by S. 
pneumoniae (Otero et al., 2013). Therefore, we analyzed the TLR10 expression in normal 
and asthmatic lungs. Lung sections stained with vWF showed positive staining in the 
vascular endothelium (Fig. 6A) while replacement of the primary antibody with an 
isotype-matched antibody (Fig. 6B), or omission of primary antibody altogether (data not 
shown) resulted in absence of reaction. TLR10 expression was observed in endothelium 
and sub-epithelial area of bronchiole (Fig. 6C) of normal human lung. Asthmatic lungs 
showed elevated expression in both endothelium and alveolar septa (Fig. 6D-F). The data 
indicate that TLR10 expression is changed during infection and chronic inflammation 

















































































Nucleus TLR10 Merge 
 
 
Figure 5. 1: Effect of S. pneumoniae in TLR10 expression in human macrophages 
(A) U937 derived macrophages (1 X 106 cells) were infected with live invasive culture of 
S. pneumoniae (105 cfu, 106 cfu, 107 cfu, 108 cfu) for 6hr at 37°C. Total mRNA isolation 
was performed and is used for quantitative real time PCR. Fold change was calculated 
using ΔCt method. (B) U937 derived macrophages were (1 X 107 cells) infected with live 
invasive culture of 107 cfu S. pneumoniae for 3, 6, 12 and 24hrs. Total mRNA isolation 
was performed and used for quantitative real time PCR. Fold change of TLR10 mRNA 
was calculated using ΔΔCt method. *p < 0.05 considered as significant. (C) U937 




pneumoniae for 6hr and immuno-stained for TLR10 (in green) and nucleus (in blue). 
Cells were imaged using Leica SP5 confocal microscopy under oil immersion 
(Magnification. 630). (D) Corrected total cell fluorescence was calculated from integrated 
density, area and mean fluorescence. Raw data was analyzed using t test. *p < 0.05 




































Nucleus TLR10 Merge 2B 
 
Figure 5. 2: TLR10 silencing using RNA interference 
(A) U937 derived macrophages (1 X 106 cells) were transfected with 80nM of TLR10 




obtaining 80% confluence in culture. Total mRNA was isolated and used for quantitative 
real time PCR. Fold change of TLR10 mRNA was calculated using ΔΔCt method. *p < 
0.05 considered as significant. (B) TLR10 silenced macrophages (1 X 106 cells) were 
immuno-stained for TLR10 (in green) and nucleus (in blue). Cells were imaged using 
Leica SP5 confocal microscopy under oil immersion (Magnification. 630). One 


























































































































































Figure 5. 3: TLR10 silencing reduced the production of proinflammatory cytokines 
U937 derived macrophages were transfected with TLR10 siRNA to silence TLR10 
expression as explained.  Control and TLR10 knockdown macrophages (1 X 106 cells) 
were challenged with live invasive S. pneumoniae (107 cfu, 6hr). Total mRNA isolation 
was performed after the incubation time and carried out quantitative real time PCR to 
determine the expression levels of IL-1 (A), IL-8 (B), IL-17 (C), TNF-α (D) and IL-10 
(E). Primer sequences were listed in Table. 1. Fold change of TLR10 mRNA was 
calculated using ΔΔCt method. *p < 0.05 considered as significant. One representative of 




















































Figure 5. 4: TLR10 silencing did not affect macrophage phagocytosis 
(A) Control and TLR10 silenced U937 derived macrophages (1 X 106 cells) were treated 
with fluorescent labeled live invasive culture of S. pneumoniae (107 cfu, 6hr; in green). 
Cells were immuno-stained for TLR10 (in pink) and nucleus (in blue). Cells were imaged 
using Leica SP5 confocal microscopy under oil immersion (Magnification. 630). (B) 
Number of phagocytosed bacteria was counted and analyzed using student t test. p value 


















Nucleus NF-κB Merge 
5A 
























Figure 5. 5: TLR10 silencing reduced NF-κB nuclear translocation 
(A) Control and TLR10 silenced U937 derived macrophages (1 X 106 cells) were treated 
with live invasive culture of S. pneumoniae (107 cfu, 6hr). Cells were immuno-stained for 
NF-κB (in green) and nucleus (in blue). Cells were imaged using Leica SP5 confocal 
microscopy under oil immersion (Magnification. 630). (B) Western blot of NF-κB from 
nuclear isolates of the macrophages (control and TLR10 knockdown) treated with 107 cfu 
S. pneumoniae for 6hr and (C) shows the densitometric quantification. One representative 




















Figure 5. 6: TLR10 expression in human lungs  
Human lung sections were stained with vWF antibody (A) and show staining in 
endothelium (arrows) but not in bronchiolar epithelium, and isotype-matched antibody 
(B) lacks staining. Lung from a control subject (C) shows staining (red arrows) in 
endothelial area of a blood vessel (BV). Bronchiolar epithelium (black thick arrows) 
shows no staining for TLR10. The TLR10 staining is increased in a lung from an 
asthmatic patient (D, E &F) compared to the control. Magnification 100 (A-D), 400 (E) 





Table 5.1: List of primers  
Gene Forward primer Backward primer 
TLR10 ACTTTGCCCACCACAATCTC CCCAGAAAAGCCCACATTTA 
GAPDH GAGTCAACGGATTTGGTCGT TTGATTTTGGAGGGATCTCG 
IL-10 TGGTGAAACCCCGTCTCTAC CTGGAGTACAGGGGCATGAT 
TNF-α ACATACTGACCCACGGCTTC GCACTCACCTCTTCCCTCTG 






TLRs are highly conserved innate immune receptors, which detect specific 
pathogen associated antigenic patterns.  While TLR10 was identified a few years ago 
(Chuang and Ulevitch, 2001), little is known about the function and ligand of TLR10.  
When first identified, TLR10 mRNA expression was shown in organs such as brain, 
lungs, kidney, pancreas, spleen, lymph nodes and immune cells  (Chuang and Ulevitch, 
2001). We found that TLR10 regulates the production of IL-1, IL-8, IL-17 and TNF-α via 
NF-κB pathway in macrophages infected with S. pneumoniae. We provide the first 
immunohistological data that TLR10 is expressed in normal and asthmatic human lungs.  
Asthmatic lungs are susceptible to viral and bacterial infections (Sutherland and 
Martin, 2007; Busse et al., 2010; Rosenthal et al., 2010). S. pnuemoniae is one of the 
most common bacterial infection in the lungs of humans suffering from asthma. 
Therefore, we examined the effects of S. pneumoniae infection on macrophages derived 
from U937 ell line. The exposure of U937 cells to S. pneumoniae altered the temporal 
and spatial expression of TLR10. TLR10 expression in the macrophage cell line was 
significantly increased at 107 and 108 cfu but not at lower infection dosages. Having 
determined dose-dependent increased in the TLR10 expression, we further found that 
increase in expression was also time-dependent with maximal expression observed at 6hr. 
Interestingly, TLR10 mRNA was not detected at 12hr post-infection but was observed at 
24hr. The mRNA data were supported through TLR10 protein immunofluorescence 
experiments that provided evidence of increased TLR10 expression in the cytoplasm of 
macrophages. Taken together these are the first data to show that S. pneumoniae infection 




Bacterial infections activate immune cells such as macrophages leading to 
production of variety of inflammatory mediators (O'Riordan et al., 2002; Torraca et al., 
2014; Wegiel et al., 2014). We used a panel of inflammatory mediators as a biological 
readout of the role of TLR10 in S. pneumoniae infection through knocking down TLR10 
in the macrophage cells. Through the use of siRNA, the TLR10 mRNA and protein 
expression was significantly reduced. We used this system to assess the effect of TLR10 
on the production of selected cytokines. We selected IL-1β, IL-8, IL-17 and TNF-α for 
their roles as pro-inflammatory cytokines in bacterial infections and IL10 as a regulatory 
and anti-inflammatory cytokine (Cavaillon, 1994; Stow et al., 2009; Varin and Gordon, 
2009; Scull et al., 2010; Lacy and Stow, 2011). The production of IL-1β, IL-8, IL-17 and 
TNF-α mRNA but not IL10 mRNA was significantly reduced in the macrophages with 
TLR10 knockdown to suggest its role in production of these inflammatory mediators in 
macrophages infected with S. pneumoniae. Host response against S. pneumoniae 
infection includes the activation of humoral and cell mediated immunity along with 
changes in expression levels of cytokines and chemokines (Wilson et al., 2014). Changes 
in cytokine mRNA levels in S. pneumoniae infected TLR10 knockdown macrophages, 
suggesting TLR10 might involve in the immune sensing of gram-positive bacterial 
infections. Regan et al showed the proinflammatory role of TLR10 in L. monocytogenes 
infection in THP-1 cells (Regan et al., 2013). The data show a novel role for TLR10 in 
the production of inflammatory mediators in macrophages infected with S. pneumoniae.  
 
We further explored the mechanisms through which TLR10 may be regulating the 




phagocytosis. The experiment using S. pneumoniae labeled with fluorescent markers 
showed that TLR10 knockdown did not affect phagocytosis. This is in contrast to the role 
that TLR4, which has a positive effect on macrophage phagocytosis E. coli by 
interperitoneal macrophages (Anand et al., 2007).   Among the TLRs, TLR9 being the 
strongest and TLR3 being the weakest inducer of macrophage phagocytosis through 
regulating interleukin-1 receptor–associated kinase-4 and p38 signalling (Doyle et al., 
2004). Our data shows TLR10 doesn’t regulate phagocytosis of S. pneumoniae by 
macrophages. After this we examined whether TLR10 affects transcription factor NF-κB, 
and found that TLR10 knockdown leads to a reduction in the expression of NF-κB and its 
reduced localization into the nucleus of infected macrophages.  Previously, NF-κB 
mobilization by hypoxia has been shown to upregulate TLR10 mRNA (Kim et al., 2010). 
Our data show that TLR10 regulates production of inflammatory cytokines through 
activating the nuclear translocation of NF-kB but through affect on the phagocytosis of 
bacteria.  
The finding of immunomodulatory roles of TLR10 has important consequences. 
First of all, this study elucidates a biological function for TLR10 in macrophages’ 
response against S. pneumoniae. The data assume significance because TLR10 is still one 
of the least studied TLR largely due to lack of knowledge on the identity of its ligand and 
lack of functional TLR10 in mice. The ability of bacteria to alter TLR10 expression and 
the regulation of cytokine production by TLR10 in infected macrophages will create 
opportunities to better understand the mechanisms of bacterial disease such as that caused 
by S. pneumoniae. The production of pro-inflammatory cytokines but not anti-




component of host’s immune response, which these bacteria may subvert. Such insights 
may be relevant for the development of novel treatment strategies based on modulation of 




CHAPTER 6: GENERAL DISCUSSION  
 
Primary aims of this project were to investigate the expression and function of 
TLR10 in immune cells, and to delineate expression of TLR10 in lung of humans as well 
as in commercially important domestic animal species. Since TLRs are the guardians of 
innate immune system, I examined the role of TLR10 in neutrophil chemotaxis and 
innate immune response towards S. pneumoniae infection. We report previously 
unknown roles of TLR10 in neutrophil chemotaxis and responses of macrophages 
towards S. pneumoniae, which will enhance our understanding of fundamental biology of 
TLR10 and mechanisms of inflammatory diseases.  
I have characterized the expression of TLR10 in chicken, cattle, pig, dog, rats, and 
human lungs. Prior to our study, there were no data available on the expression of TLR10 
in lungs of these species. However, the expression kinetics of human TLR10 in intestine, 
tonsils and in liver has been reported recently (Chuang and Ulevitch, 2001; Bourke et al., 
2003; Regan et al., 2013). First, I performed homology analysis and protein sequence 
alignment of the peptide used to produce a commercially available anti-human TLR10 
polyclonal antibody against the TLR10 peptide sequence of chicken, cattle, pig, rat, and 
dog. This was needed because of a lack of a species-specific commercial antibody for use 
in these species. Because the spatial cell-specific expression is highly informative in 
understanding the role of molecules such as TLR10, I used in situ light and electron 
microscopic immunochemistry.  The expression of TLR10 was located in the lungs of all 
the species, and the electron microscopy showed TLR10 in the cytoplasm, plasma 
membrane and nucleus of lung cells. TLR10 expression was also observed in pulmonary 




macrophages present in species such as cattle, sheep, goat, pigs, and horse and 
phagocytose blood-borne particles (Winkler, 1988; Chitko-McKown et al., 1991; Singh, 
2004; Schneberger et al., 2012). I found evidence of altered expression of TLR10 in 
inflamed lungs from pig, cattle and chicken. The alterations in cell-specific in situ TLR10 
data in inflamed lungs compared to the normal suggest a potential regulatory effect of the 
microbes on the expression of TLR10. The data on the expression of TLR10 does set the 
stage to explore its specific roles in lung biology 
The immune cells such as neutrophils are the first responders in acute 
inflammation including that in the lungs (Snyder et al., 1991; Pasparakis and 
Vandenabeele, 2015). Because the identity of ligand for TLR10 is unknown, I used E. 
coli LPS as an agonist to stimulate neutrophils. Because the in situ data from multiple 
species showed TLR10 in neutrophils located in the lungs, I examined the expression of 
TLR10 in normal neutrophils and those treated with E. coli LPS. While the LPS 
treatment did not change the amount of TLR10 in the neutrophils, there were alterations 
in spatial expression. Following this, I examined the human peripheral blood neutrophils. 
As the first step to understand TLR10 biology, I used multiple methods to examine the 
TLR10 expression in detail and the mechanisms that regulate its expression in 
neutrophils. The activated neutrophils showed that lipid-raft mediated endocytosis of 
TLR10 altered its localization on the plasma membrane. There are many other instances 
where lipid-rafts have been shown to influence the dynamics of molecules including 
TLRs located in the plasma membrane of various cells (Szabo et al., 2007; Daniel and 
Kai, 2010; Zhu et al., 2010).  An interesting aspect of the data is that TLR4-mediated 




expression of TLR10. NF-κB activation is reported to have effect on the changes in 
expression of TLR2, 4 and 9 mRNA in human dendritic cells (An et al., 2002; Kawai and 
Akira, 2007).  
 
During a curiosity-driven live cell imaging experiment, which was prompted by 
immuno-electron microscopic localization of TLR10 on the leading edge of neutrophils, I 
observed dynamic localization of TLR10 into the pseudopods of activated neutrophils. It 
is well known that neutrophils upon activation migrate towards the site of inflammation 
or infection as one of their primal function (Zachariae, 1993; Cicchetti et al., 2002).  
There are few existing data on the role of TLRs, especially TLR4, in neutrophil 
chemotaxis. Many of these data on the role of TLRs in neutrophil chemotaxis are 
contradictory (Fan and Malik, 2003a; Hayashi et al., 2003; Khan et al., 2005; Sabroe et 
al., 2005; Aomatsu et al., 2008b; Alves-Filho et al., 2009; Yi et al., 2012b). This 
experiment prompted further experiments including the use of HL-60 cells to examine the 
role of TLR10 in chemotaxis. Using siRNA to knockdown TLR10, I did observe that 
TLR10 is required for fMLP-directed migration of neutrophils. The TLR10 knockdown 
reduced the number of pseudopods on activated neutrophils. My efforts to establish a 
mechanism for the role TLR10 in the formation of pseudopods via regulation of actin-
nucleation proteins were not conclusive. Therefore, further experiments are needed to 
address the mechanisms through which TLR10 regulates the migration of neutrophils. 
This however does not affect the novelty of the observations that TLR10 plays a role in 
the migration of neutrophils because it advances our understanding of mechanisms of 




Asthmatic lungs are susceptible to viral and bacterial infections and S. 
pneumoniae is one of the most common bacterial infections in the lungs of humans 
suffering from asthma (Sutherland and Martin, 2007; Busse et al., 2010; Rosenthal et al., 
2010). Macrophages are credited with regulation of lung inflammation in variety of 
conditions including asthma (Wojcik et al., 2008; Herold et al., 2011; Hiraiwa and van 
Eeden, 2013). Because I reported the expression of TLR10 in normal and asthmatic 
lungs, I proceeded to examine the question whether TLR10 has a role in the responses of 
U937-derived macrophages against S. pneumoniae infection. Again using the siRNA 
technology, I found that reduced expression of TLR10 significantly reduced the 
production of IL-1β, IL-8, IL-17 and TNF-α mRNA but not IL10 mRNA in macrophages 
infected with S. pneumoniae. However, the phagocytosis of the bacteria was not affected. 
This is in contrast the data that TLR3 and 4 regulate phagocytosis by macrophages 
(Anand et al., 2007). These are intriguing data because bacteria may down-regulate 
TLR10 expression to reduce production of cytokines and potency of the inflammatory 
response to avoid their elimination. I believe further experiments are needed to find out 
whether TLR10 has a function in the degradation of bacteria by the macrophages.  
Taken together these data show that there is a homologous and constitutive 
expression of TLR10 across different species. Further, when TLR10 was silenced in 
neutrophils and macrophages exposed to LPS and S. pneumoniae, respectively, there 
were significant alteration in their chemotactic and immune responses. The finding of 
potential functional roles of TLR10 has significant consequences. Importantly, this work 
explains the possible biological function for TLR10 in response to bacterial LPS and S. 




pathology of bacterial infections. Such insights may be relevant for the development of 




CHAPTER 7: LIMITATIONS OF THE STUDY 
 
In spite of the fact that the data from my study furthers our understanding on 
functional role of human TLR10, there are some limitations as well.  This study couldn’t 
provide the conclusive evidence of mechanisms through which TLR10 alters neutrophil 
chemotaxis. The study does not provide protein data to support the transcriptional level 
changes in pro-inflammatory mediators in macrophages infected with S. pneumoniae. 
The work on domestic animal species also utilized lungs from various species that were 
infected by bacteria or viruses or injected with endotoxin thus leading to difficulty in 




CHAPTER 8: FUTURE DIRECTIONS 
Future studies are required to explain the molecular mechanisms through which 
TLR10 regulates neutrophil chemotaxis. Since TLR10 is not functional in mice, there 
also is a need to develop a new model system to study the functional aspects of TLR10 in 
innate immunity. I have only examined isolated primary neutrophils and U937 derived 
macrophages for TLR10 expression and dynamics. Hence these studies should be 








Supplementary Figure 4.1: LPS (60min) challenge upregulated TLR10 mRNA 
Human neutrophils were (1 X 107 cells) treated with LPS (1µg/ml) for 60, 90 and 
120min. Total mRNA isolation was performed and used for quantitative real time PCR. 
Fold change of TLR10 mRNA was calculated using ΔΔCt method. *p < 0.05 vs control, 












Supplementary Figure 4.2: Low temperature disruption of endocytic pathway 
inhibited TLR10 internalization 
(A, B) Human neutrophils (1 X 106) adhered to FBS coated coverslips; low temperature 
disruptions of endocytic pathway were performed and were activated by LPS (1µg/ml). 
Merged panel shows TLR10 (red), nucleus (blue) and early endosomal antigen, EEA1 















Supplementary Figure 4.3: Lipid raft disruption inhibited TLR10 endocytosis 
(A, B) Human neutrophils (1 X 106) adhered to FBS coated coverslips; low temperature 
disruptions of endocytic pathway were performed and were activated by LPS (1µg/ml). 
Merged panel shows TLR10 (red), nucleus (blue) and early endosomal antigen, EEA1 
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